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Schmitt, Paul D. Ph.D., Purdue University, August 2016. Coupling Qualitative and 
Quantitative Analyses of Pharmaceutical Materials Enabled by Second Harmonic 
Generation Microscopy. Major Professor: Garth J. Simpson. 
The detection and characterization of crystallinity is critical throughout the drug 
development process. From the initial establishment of an active pharmaceutical 
ingredient’s (API) crystal structure to stability testing and quality control, the phase of an 
API affects the solubility, bioavailability, stability, and efficacy of a drug product. 
Second harmonic generation (SHG) microscopy has recently been developed as a 
selective and rapid method for imaging crystallinity in drug formulations. While SHG 
microscopy can enable the high signal-to-noise (SNR) detection of crystallinity, the 
intrinsic chemical information content within SHG images is relatively low. In cases of 
trace crystallinity and/ or small crystal volumes, new tools capable of rapid, qualitative 
crystal characterization are needed to fill this measurement gap. Several strategies for 
increasing the chemical information content of SHG microscopy were developed. 
Following combined computational and experimental studies to help determine the body 
of crystalline API structures amenable to imaging by SHG microscopy, measurements by 
confocal Raman spectroscopy and synchrotron X-ray diffraction  were performed on 
regions of interest (ROI) identified by SHG. In both cases, spatial restriction of the 




and synchrotron X-ray diffraction by several orders of magnitude. To further expand the 
capabilities of SHG microscopy, nonlinear optical Stokes ellipsometric (NOSE) 
microscopy was developed to assess crystal structure characteristics through the 
polarization dependence of SHG. Rapid (8 MHz) polarization modulation enabled NOSE 
microscopies at video rates (up to 15 Hz). Following development and validation, NOSE 
microscopy was used in conjunction with an iterative, nonlinear least-squares fitting 
algorithm to discriminate polymorphic crystal forms of the small molecule D-mannitol. 
Finally, to extend the linear dynamic range of photon counting measurements as 
described here-in, a novel digital filter derived from linear discriminant analysis (LDA)  





CHAPTER 1. INTRODUCTION 
1.1 Background and Motivation 
An increasingly large percentage of emerging active pharmaceutical ingredients 
(APIs) experience significant formulations challenges due to low bioavailability 
stemming from poor aqueous solubility.1,2 It is estimated that 70-90% of new chemical 
entities (NCEs) under development are in danger of being abandoned as therapeutic 
molecules.3,4 The advent of solid dispersions, in which the API is cast in an amorphous 
state within a polymer matrix, has been shown to be an effective strategy for increasing 
the aqueous dissolution kinetics of such APIs.5,6 Unfortunately, this increase in solubility 
is primarily contributable to an increase in product free energy. Such amorphous 
formulations are thus in danger of crystallizing over time, leading to a compromise of 
formulation stability, shelf-life, and ultimately therapeutic effect.7 Thorough knowledge 
of any trace crystalline content and polymorphic crystalline form of an API within an 
amorphous formulation is paramount to ensuring proper therapeutic effects.  
1.2 Past Efforts in Pharmaceutical Crystal Analysis 
 Second harmonic generation (SHG) microscopy has recently been demonstrated 
as a fast, selective, and sensitive technique for imaging trace crystallinity within bulk 
amorphous materials and API final dosage forms.8–10 Crystalline detection limits for SHG 
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microscopy are on the order of parts per billion (ppb),9 demonstrating a significant 
decrease from the ~1% detection limits of orthogonal techniques such as powder X-ray 
diffraction (PXRD), Raman/ IR spectroscopies, differential scanning calorimetry (DSC), 
and solid state NMR (ssNMR), among others.11–18 The ability to detect low (<1%) levels 
of crystallinity is important for characterizing trace crystallinity in amorphous 
formulations, particularly for final dosage forms at low (5-10% w/w) overall drug 
loadings (DLs). Even in the case of complete API crystallization at these low DLs, the 
total crystalline content may approach the limits of detection of these common analysis 
techniques. Partial crystallization of low DL formulations presents further measurement 
challenges, as the total mass fraction of crystalline API may approach that of other 
impurities within the product. Knowledge of crystal identity and polymorphic form 
within such formulations is thus critical to ensuring drug stability, solubility and proper 
therapeutic function. While SHG microscopy has been shown to be a powerful technique 
for the detection and quantification of trace crystallinity, the inherent chemical 
information content of SHG is intrinsically low. The bulk selection rule for SHG merely 
requires materials that are noncentrosymmetric, and little to no spectral information is 
probed in the course of the measurement. Accordingly, confirmation of crystal chemical 
identity and lattice structure is difficult to perform by SHG microscopy alone. New 
analysis tools enabling rapid, qualitative characterization of trace crystallinity are needed 






1.3 Thesis Overview 
Crystal analysis based on SHG microscopy has the potential to reduce bottlenecks 
in many stages of the drug development pipeline. To first assess the potential 
compatibility of a variety of APIs with analysis by SHG, a model for predicting the 
relative SHG activities of emerging drug molecules was developed and compared to 
experimental results. Time-dependent Hartree-Fock calculations were first performed for 
the molecular building block (i.e., the API), with subsequent application of an analytical 
model describing the symmetry of the crystal lattice. Trends of relative SHG activity for 
18 common APIs generally agreed well with experimental results, with outliers primarily 
attributed to the presence of trace quantities of unanticipated, metastable SHG-active 
crystal forms present in the commercial powder. These results demonstrate both the 
broad utility of API crystal analysis by SHG, as well as the ability of relatively simple 
models to predict SHG activity ab initio.  
 Due to the relatively high detection limits (~1%) of common crystal analysis 
techniques (PXRD, Raman), the trace levels of crystallinity potentially found in 
amorphous formulations present measurement challenges for characterizing not only the 
overall crystalline content, but also crystal chemical identity and structure. Coupling 
SHG to these orthogonal techniques can enable analysis of trace crystallinity well-below 
the detection limits of spectral measurements taken alone. SHG-guided Raman 
spectroscopy was used for the analysis of the commercial amorphous anti-cancer 
formulation Abraxane (nanoparticle albumin-bound paclitaxel). SHG indicated the 
presence of trace-crystalline domains within the powdered sample. Raman spectra of the 
SHG-active domains were consistent with Raman spectra of pure crystalline paclitaxel. 
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Coupling these two approaches enabled chemical characterization of regions of interest 
identified by SHG while simultaneously reducing the time required for characterization 
by Raman spectroscopy through informed beam placement. Similarly, SHG-guided 
synchrotron X-ray diffraction (XRD) was used to characterize crystal identity and lattice 
structure in a trace (100 ppm) physical mixture of crystalline ritonavir (RTV) in the 
common excipient hydroxypropyl methylcellulose (HPMC). A combined microscope 
integrating SHG into a synchrotron beam line (23-ID-B, Advanced Photon Source, 
Argonne National Laboratory) enabled diffraction measurements from a 5 m 
synchrotron beam selectively targeted to regions of interest identified by SHG. Observed 
diffraction patterns were indexed and agreed well with theoretical diffraction patterns for 
RTV. These combined measurements lower the detection limits of synchrotron XRD into 
the ppm regime while simultaneously validating ppm-level crystal detection by SHG 
microscopy. 
 In addition to coupling SHG to orthogonal methods such as Raman and XRD, 
new instrumentation enabling rapid polarization modulation in SHG microscopy also has 
the potential to probe structural properties of crystals. As the symmetry properties and 
orientation of the crystal lattice affect the relative SHG efficiency for given incident 
polarizations, modulation of the driving electric field and measurement of the 
polarization state of the second harmonic can be used to probe structural properties of the 
crystal. Rapid (8 MHz) polarization was performed with an electro-optic modulator 
(EOM), enabling polarization-modulated SHG imaging at video rates. Following initial 
validation of the instrumentation using Z-cut quartz, polarization-modulated SHG 
microscopy was used to discriminate two polymorphic crystalline forms of the small 
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molecule D-mannitol. Discrimination was optimized when the orientational effects were 
removed from the polarization-dependent response via a novel iterative, nonlinear least-
squares fitting algorithm. Discrimination of orthorhombic and monoclinic crystal forms 
was achieved within the 99.99% confidence interval. 
Finally, post-data acquisition strategies to increase the signal to noise ratio (SNR) 
of nonlinear optical (NLO) images have the potential to benefit this collective set of 
measurements. For imaging based on photon counting, the upper limit on the linear 
dynamic range (LDR) of the measurement is severely restricted due to temporal pulse 
pile-up in the raw voltage transients emerging from the photomultiplier tube (PMT). 
Digital strategies to increase this LDR enable higher accuracy in quantitative NLO 
measurements. A novel digital filter derived from linear discriminant analysis (LDA) was 
developed and found to improve the LDR of photon-counting measurements by 
approximately 3 orders of magnitude. The digital filter is derived from a 2-class 
discrimination, in which time-coincident and non-coincident voltage transients form the 
two populations to be discriminated. The digital filter was also applied to experimental 
two-photon excited UV fluorescence (TPE-UVF) images of crystalline tryptophan, and 
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CHAPTER 2. AB INITIO PREDICTION OF THE DIVERSITY OF SECOND 
HARMONIC GENERATION FROM PHARMACEUTICALLY RELEVANT 
MATERIALS 
2.1 Introduction 
The physical and chemical properties of active pharmaceutical ingredients (APIs) 
are highly dependent on the crystal form. Currently, many techniques are used to detect 
and understand crystallinity and polymorphism throughout the drug development process. 
During initial development, visual inspection, polarized light microscopy, thermal 
microscopy, differential scanning calorimetry (DSC), Raman spectroscopy, and X-ray 
diffraction (XRD) can be used to assess the results of multi-well plate crystallization 
experiments.1–6 While the sample matrix generally lacks competing materials (no buffer 
salts, etc.) that would interfere with drug crystal detection, assessment of plates by these 
techniques often requires several hours of measurement per plate due to long signal 
integration times, as is often the case with Raman spectroscopy and XRD. The same 
limitations are found later in the pipeline, where the presence of various excipients and/or 
turbid matrices requires extensive signal averaging. Here again the detection of trace 
crystallinity is of utmost importance, as amorphous and co-crystal formulations are 
increasingly being used to enhance the bioavailability of poorly water-soluble drugs.7–10  
Second harmonic generation (SHG) microscopy has recently emerged as a 
complementary tool for the detection and analysis of chiral crystals.11 The symmetry-
8 
 
properties of SHG enable the selective detection of chiral crystal formation within 
amorphous media with detection limits many orders of magnitude lower than alternative 
bench-top methods.12–14 Potential applications of SHG imaging include initial high-
throughput screening of crystallization conditions and optimization of amorphous 
formulations. However, the inherent SHG activity of APIs can span many decades and be 
highly dependent on the crystal lattice structure, such that different molecules can exhibit 
large inherent disparities in intrinsic SHG activity, and the same target molecule can 
exhibit radically different SHG activities in different crystal polymorphic forms. This 
diversity in activity can challenge the design of experiments to assess likely compatibility 
of target molecules and crystals with SHG analysis. A need has emerged for the 
development of reliable methods for ab initio prediction of the anticipated SHG activity 
of crystal forms to aid in both initial assessment of target compatibility and polymorph 
analysis.  
The primary goal of the present study is to quantitatively assess the merits of a 
weak-coupled oscillator model for the ab initio prediction of the SHG activities of API 
crystal forms. In brief, the SHG activities of crystals are predicted based on the calculated 
molecular hyperpolarizabilities and the symmetry properties of the lattice in the limit of 
negligible perturbation from intermolecular electronic interactions. Converting from the 
molecular hyperpolarizability to the material susceptibility is achieved based on the bulk 
number density of chromophores,15 which was evaluated based on the known lattice 
constants of the crystals. The SHG intensities of the powder are then calculated using the 
isotropic invariants in expressions describing hyper-Rayleigh scattering.16 Pure 
crystalline powders of these same and additional APIs and excipients were then analyzed 
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experimentally for their observed SHG response, with sample preparation methodology 
similar to that of Kurtz-Perry.17–20 
2.2 Materials and Methods 
All calculations were done using the General Atomic and Molecular Structure 
System (GAMESS) quantum chemical package.21  Each hyperpolarizability calculation 
was performed using time-dependent Hartree Fock (TDHF) using a restricted Hartree 
Fock self-consistent field with a 6-311G basis set including d and p heavy atom 
polarization functions and diffuse L-shell on heavy atoms. The incident energy for all 
calculations was chosen to be 0.043 Hartrees, corresponding to the 1060 nm incident 
beam used in the experiments. Unmodified atomic geometry coordinates were obtained 
from the Cambridge Structural Database (CSD). Avogadro software,22 version 1.0.3, was 
used to convert the files to GAMESS input cards.  Chimera NLOPredict was used for the 
tensor evaluations and visualizations.23 Calculations were performed on the following 
molecules with TDHF: benzocaine (QQQAXG05), captopril (MCPRPL), clarithromycin 
(NAVSUY), D-(-)-salicin (CIZWOX), dexamethasone (DEXMET11), efavirenz 
(AJEYAQ02), flutamide (WEZCOT), griseofulvin (GRISFL03), itraconazole (TEHZIP), 
ketoconazole (KCONAZ), loratadine, mevastatin (COMPAC), naproxen (COYRUD12), 
quinidine (BOMDUC), tacrolimus (XAVZIF), tadalafil (IQUMAI), tolazamide 
(CABCUD01), and triamcinolone (QETZUL). In the event of multiple entries in the 
CSD, the structure chosen for calculations was the most recent deposit of the correct 
polymorphic form. All quantum chemical calculations indicated the absence of 
resonances within the visible spectrum, with the lowest electronic resonances lying in the 
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ultraviolet regime. Furthermore, visual inspection indicated each sample to be a white 
powder, consistent with the absence of resonances in the visible portion of the spectrum 
and consistent with expectations of the quantum chemical calculations.  
From the molecular β(2) tensors, the (2) tensors of the crystals were estimated by 
performing the symmetry operations of the lattice as described previously and accounting 
for the lattice volume.24,25 In both studies, the bulk crystal NLO properties were 
approximated by averaging the orientations of the individual molecular tensors and then 
taking their coherent sum. The “symmetry additive” approach used in the present study 
neglects perturbations to the electronic properties of the materials from intermolecular 
coupling. In general, intermolecular interactions will result in splitting to form exciton 
states that ultimately result in a band structure in a lattice. While such effects can have a 
profound impact on the nonlinear optical response close to resonance, it has been shown 
previously by quantum chemical methods that the perturbations are only significant close 
to resonance with the accuracy of the simple symmetry-additive model retained in 
measurements performed far from resonance.26,27 These theoretical trends are supported 
by experimental measurements in proteins, in which the intramolecular coupling from 
strong chromophores28 and amide groups29 is likely to be significantly greater than 
intermolecular interactions between APIs within a crystal. A graphical illustration of this 
process is shown in Figure 1 for the P212121 lattice of captopril. In this case three 
orthogonal ܥଶ rotations were performed about the three principal axes. Although the 
symmetry operations formally correspond to combinations of both rotation and 
translation, the translation distance is much less than the wavelength of light and can 
reasonably be neglected in the analysis. Each individual panel is a visual hyper-ellipsoid 
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representation of the molecular (2) tensor, the length of which corresponds to the 
magnitude of the zzz projection along that direction in space and the color of which 
indicates the sign of the emerging field (red = negative, blue = positive).30 Coherent 
summation of the four different captopril orientations present within the lattice leads to 
the net response indicated to the right in the figure. In addition to the hyper-ellipsoid 
representation, a complementary vector-sphere representation is also shown. Whereas the 
hyper-ellipsoid only indicates the projection onto the normal of the sphere, the vector-
sphere, or unit sphere, recovers the polarization direction of the nonlinear field and is 
therefore a more complete map.31 Finally, the tensor was then scaled based on crystal 
packing density by simply dividing by the unit volume to produce the crystal (2) 
susceptibility. In the case of structures with Z' > 1, the summed responses of the 
asymmetric units within the unit cell were calculated. First, calculations were performed 
for one of the molecules in the asymmetric unit. As the conformational differences 
between the unique monomers were all quite subtle, the tensor for the other unique 
monomers was generated by reorientation of the molecule using NLOPredict.23 The 
hyperpolarizability for each asymmetric unit was then coherently summed prior to the 
calculation of the bulk crystal susceptibility based on the symmetry operations of the 
lattice. 
The anticipated intensity of the crystalline powder was calculated based on the 
assumption of statistical sampling of equally probable crystal orientations and sizes. 
Incoherent addition of signals from the many independent random sources becomes 
mathematically equivalent to hyper-Rayleigh scattering. Using the isotropic invariants 
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described by Bersohn et al.,16 the integrated SHG detected in the direction co-axial with 
the beam propagation was used in the predicted intensities. 
The instrument utilized for sample analysis is a commercially-available 
Formulatrix SONICC system powered by a Fianium FemtoPower laser, 1060 nm, 
capable of producing 1.3 W, 51 MHz repetition rate, and a 166 fs pulse width. Multiple 
models of this instrument are available, with various detector configurations. The model 
utilized in this study collected SHG light in the transmission direction, and two-photon 
excited UV fluorescence (TPE-UVF) light in the reflected (epi) direction, with the latter 
generated by passing the 1060 nm light through a lithium triborate doubling crystal prior 
to the sample, generating 530 nm light. While theoretical TPE-UVF activities were not 
calculated, the collection of TPE-UVF data was prudent for several reasons, including: 
aiding in the analysis of outliers, experimental demonstration of an equally large dynamic 
range for TPE-UVF, and the relative ease of obtaining additional data given the 
automation of the measurements on the commercial platform. 
Sample preparation can significantly influence the degree of scattering of both the 
incident laser and the signal that is generated. The samples were sieved resulting in a 
particle size range between 106-250 µm (tacrolimus and tadalafil were not sieved due to 
limited sample quantity and cost constraints). Once sieved, the powdered samples were 
placed between two glass cover slips and filled to the tops of binder reinforcement rings, 
allowing for uniform sample thickness (~150 µm),. Four replicates of each sample were 
prepared, and within each sample, three spots were examined for a total of 12 replicate 
measurements per API. Due to the variability of sample and sample-holder positioning, a 
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1 mm distance in the z-direction (parallel to beam propagation) was probed in 40 µm 
steps to ensure the entire sample was imaged.  
Due to the inherent variability in both the SHG and fluorescence activities of 
APIs, multiple acquisition profiles were necessary to remain within the linear dynamic 
range of the photon counting hardware used. The incident laser powers at the sample 
along with acquisition times are listed in Table 1 for each unique acquisition profile. The 
instrument utilizes beam-scanning at ~8 kHz, allowing for higher incident laser powers 
while also mitigating sample damage. All measurements were performed with a fast-
scanning approach designed to reduce sample perturbations from the optical beam. Each 
focal volume was sampled for <125 ns per passage of the beam with ~125 µs allowed for 
heat dissipation prior to resampling. Furthermore, resampling was performed no more 
than 60 times per focal volume (corresponding to a ~2 s image integration time), for a 
total exposure of less than 2 µs in any given focal volume. Furthermore, all 
measurements were performed with an incident wavelength of 1060 nm and a 
corresponding doubled wavelength 530 nm to avoid electronic resonances and absorption 
at the fundamental or second harmonic frequencies. The laser was focused onto the 
sample with a pseudo-10x objective providing a 500 x 500 µm field of view, 
corresponding to 512 8-bit pixels on each axis. 
Each field of view for the data collected was averaged and stacked (NIH 
ImageJ).32 The z-plane for each sample corresponding to the greatest signal intensity was 
averaged with two z-planes above and below. An average signal intensity for each API 




2.3 Results and Discussion 
A comparison of the predicted and measured SHG activities of 18 representative 
APIs is shown in Figure 2. The experimentally-determined SHG activity spanned a range 
of 7 decades, from loratadine (dimmest) to flutamide (brightest). All results were 
normalized to the experimentally observed signal generated by flutamide, as it was 
observed to have the highest SHG activity, and relative values are expressed. In general, 
good agreement was found between the predicted and observed SHG activities of the 
different APIs. In most instances, the ab initio calculations with no adjustable parameters 
were within an order of magnitude of the experimental observations from relatively 
complex mixtures of powders. Given the many factors that affect the observed SHG 
activity and the relative simplicity of the analytical model, the recovery of such good 
agreement across 7 decades of variation in signal is especially encouraging.  
The agreement between theoretical predictions and experimental trends may 
initially be surprising given the established importance of phase-matching in powders 
analysis by SHG and the absence of its consideration in the simple symmetry-additive 
model used. In conventional SHG powders analysis based on approaches initially 
forwarded by Kurtz and Perry and subsequent refinements thereof,17–20 the measured 
SHG activities recorded with a collimated or gently focused lens can vary by several 
orders of magnitude for phase-matchable versus nonphase-matchable materials. Phase 
matching arises when the effects of dispersion are countered by birefringence, such that 
some orientations of the crystal lattice produce identical refractive indices at both the 
fundamental and doubled frequencies, resulting in a semi-infinite forward coherence 
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length. In the presence of phase-matching, a substantial enhancement in the SHG activity 
is generated as the mean crystal size is increased. 
In order to minimize potential artifacts from phase-matching effects that would 
not be recovered by the quantum chemical modeling approach used, all measurements 
were performed using a 10x microscope objective with a depth of field of 20 m. Typical 
nonphase-matchable forward coherence lengths in APIs considering just dispersion alone 
are on the order of ~5-10 µm,13 which is comparable to the depth of field. Under these 
conditions, the neglect of phase-matching could result in an error in the analysis of 
approximately an order of magnitude [i.e., ~(20µm/7µm)2]. In this case, the measured 
SHG activities of phase-matchable materials would be significantly larger than predicted 
based on the model.  
Although in principle, this error from the neglect of phase-matching could be 
further reduced by using an objective with an even higher numerical aperture and 
narrower depth of field, the resulting field of view is also greatly reduced resulting in 
potential errors from limited sampling. Even with the 10x objective, results from many 
fields of view were pooled in each assessment of the crystal response in order to reduce 
bias from non-representative sampling. The decision on the magnification and numerical 
aperture of the objective was one based on the balance between these two potential 
measurement artifacts 
Experimental data for the same API provided in Figure 1 (captopril) is provided 
in Figure 3. The brightfield, SHG, and TPE-UVF images are shown in Figures 3a, 3b, 
and 3c, respectively. The field of view for all three images is 500 x 500 m. A 3D 
rendered threshold image utilizing multiple z-planes and NIH ImageJ was utilized to 
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generate Figure 3d. A line trace is provided in Figure 3e, showing the SHG intensity 
across the horizontal axis of Figure 3b (SHG image). 
The ketoconazole, efavirenz, and itraconazole samples were all racemates with 
centrosymmetric lattices (confirmed by the manufacturer), with the theoretical response 
therefore simply set to the dark noise limit of the instrument. However, the experimental 
results produced relatively weak but clearly detectable localized SHG. Closer inspection 
of the images for these three compounds suggests the presence of SHG-active puncta 
corresponding to a small volume fraction of noncentrosymmetric material present. The 
sparse but nonzero SHG activity is tentatively attributed to the presence of trace 
noncentrosymmetric crystals present within the mixture. Recent studies of metastable 
homochiral crystallization from racemic solutions supports the relative ease with which 
such unfavored crystal forms can be routinely produced.33 This argument is further 
supported by the much weaker SHG response observed from crystals of the achiral 
molecule loratadine, which occupies a centrosymmetric C2c space group and has no 
viable pathway to produce metastable homochiral crystal forms. Measurements for 
loratadine, which forms a centrosymmetric and SHG-inactive lattice, were also included 
to indicate the lower noise-floor limits of the instrument. In addition, it is possible that 
the puncta may potentially arise from racemic co-crystals adopting noncentrosymmetric 
lattices. Certainly, there is established literature on this topic for achiral molecular 
crystals.34–36 However, no precedent for such an occurrence could be found in a review of 
the literature for racemic co-crystals.  
A range of measured SHG and TPE-UVF activities for diverse representative 
APIs and select excipients is provided in Figure 4. This expanded list helps place the 
17 
 
APIs used for quantum chemical calculations within the scope of the broader set of 
anticipated SHG activities. It is interesting to note that the diversity in SHG activities 
spanning ~7 decades is roughly comparable to the span of signals observed using TPE-
UVF. Furthermore, little correlation between the two signals was observed, as the two 
processes arise from fundamentally different physical effects. This independence is easily 
illustrated by the different behaviors between griseofulvin (bright for both methods) and 
flutamide (among the brightest for SHG and weakest for TPE-UVF). 
It is well known that APIs have the propensity to crystallize into different 
polymorphs, resulting in dramatically different physical properties. In addition to a 
variation in solid-state characteristics, the generated SHG signal intensity depends on the 
SHG activity of the molecule as well as how the molecule arranges itself within the 
crystal lattice. The packing variability of different polymorphs can enhance or reduce the 
generated SHG response. The theoretical and experimental effects of molecular packing 
on SHG response has not yet been characterized in detail, but is material for future 
research. 
2.4 Conclusions 
 Reasonable agreement between the measured SHG activities and those predicted 
based on ab initio TDHF calculations was observed for several representative APIs. The 
seven-decade measured dynamic range of SHG activities observed for different APIs can 
complicate a priori prediction of the appropriateness of a target for SHG analysis and/or 
the selection of instrument setting consistent with the anticipated signal levels. This 
computational framework can provide a starting point for initially estimating the 
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anticipated SHG activities of small molecule crystals based on known or assumed crystal 
structures. Experimental outliers in which signals above predictions were observed in 
racemic solids from unanticipated SHG-active domains are tentatively attributed to 
homochiral metastable crystal forms. The reasonably good overall agreement between 
theory and experiment generally suggest the validity of the computational approach, 
while also providing a fairly straightforward strategy for estimating the anticipated SHG-
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Table 2.1 Incident laser powers and integration times used to ensure SHG photon counts 
remained within the linear dynamic range of the SONICC system. 
SHG Fluorescence 
449 mw, 1.8 s 260 mW, 0.45 s 
250 mw, 1.8 s 150 mW, 0.45 s 
150 mW, 0.45 s 50 mW, 0.45 s 
74 mW, 0.45 s 25 mW, 0.45 s 










Figure 2.1 Hyperellipsoid representation of the βሺଶሻtensor.  The tensor magnitude for 
each individual panel was scaled down by a factor of 15 relative to the sum on the right 





Figure 2.2 Comparison between theory and experiment for unit cell SHG activities for 
known structures. The dotted line on the diagonal is shown to visualize perfect agreement 
between experiment and theory. *Denotes a centrosymmetric crystalline space group, 





Figure 2.3 A) Brightfield B) SHG and C) TPE-UVF images of captopril. D) 3D rendering 
of the SHG image in B).E) signal profile from a line scan of the SHG image, indicated by 





Figure 2.4 Summary of experimental SHG and TPE-UVF activities for a variety of 
pharmaceutical materials. A) Observed relative SHG activities of all 42 compounds 
studied. Compounds are listed in order of decreasing SHG activity, with dashed bars 
denoting compounds for which TDHF was performed. B) Observed relative TPE-UVF 
activities of the same compounds. 
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CHAPTER 3. FINDING THE NEEDLE IN THE HAYSTACK: 
CHARACTERIZATION OF TRACE CRYSTALLINITY IN A COMMERCIAL 
FORMULATION OF PACLITAXEL PROTEIN-BOUND PARTICLES BY RAMAN 
SPECTROSCOPY ENABLED BY SECOND HARMONIC GENERATION 
MICROSCOPY 
3.1 Introduction 
Modern drug discovery frequently identifies active pharmaceutical ingredients 
(APIs) that are highly effective against the disease target, but which are hard to deliver to 
the biomedical target. Increasingly, new compounds exhibit low aqueous solubility, 
whereby it is estimated that some 40% of new chemical entities are discarded for this 
reason.1 Many solubilization strategies are designed to address this issue. One of the most 
common methods towards this end is the preparation of amorphous formulations, in 
which the API is molecularly dispersed in a non-crystalline highly soluble matrix to 
increase the dissolution rate and transient concentration.2–10 Unfortunately, most such 
formulations are inherently metastable and run the risk of spontaneously transitioning to 
their more thermodynamically stable crystalline form. If such phase changes occur either 
in the formulation preparation or during storage, significant reductions in drug 
bioavailability may arise.  
For intravenous (IV) formulations, incomplete solubilization of the API 
introduces additional embolism risks associated with blood vessel occlusion by 
circulation of poorly soluble API particulates. Therefore, various different strategies to 
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solubilize APIs are employed, including pH adjustment and/ or the use of cosolvents, 
surfactants, or emulsifiers.11–13 Unfortunately, additives used to solubilize drugs for IV 
formulations can exhibit toxicity,14,15 in some cases fatal.16 Therefore, solubilization 
strategies that minimize the use of additives with undesirable side-effects are of great 
interest. Recently, nanosuspensions17–20 such as nanoparticle albumin-bound (NAB) 
paclitaxel16 have been found to offer a potentially promising solution to this problem. 
NAB paclitaxel (PTX) is manufactured through co-precipitation with human serum 
albumin (HSA), leading to an amorphous formulation.16 Upon reconstitution, this 
formulation is a nanosuspension containing particles ca. 120 nm in diameter.  
Quantification and detection of crystallinity at low levels within such an 
amorphous formulation is often a defining measurement for predicting the long-term 
success of the product. For IV formulations in particular, crystal formation is detrimental 
because it not only reduces the solubility advantage of the amorphous formulation, but 
the presence of large, insoluble particulates is problematic and hence subject to stringent 
regulations.13,21,22 Unfortunately, for potent APIs at low loadings, accurate determination 
of crystallinity poses a significant measurement challenge. As the drug loading 
approaches the detection limits of conventional bench top methods, even major 
differences in relative drug crystallinity become difficult to distinguish with statistical 
confidence. Commonly used methods for crystal detection and characterization in the 
drug formulation pipeline include X-ray powder diffraction (PXRD), differential 
scanning calorimetry (DSC),23 Raman spectroscopy,24,25 scanning electron microscopy 
(SEM),26,27 hot stage microscopy,28 and solid-state nuclear magnetic resonance 
spectroscopy (SSNMR).29 However, most of these techniques do not typically exhibit 
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detection limits for crystallinity significantly lower than ~1%, in most cases because of 
background noise from the much larger non-crystalline fraction. Additionally, the 
composition of NAB PTX makes assessment by several of these methods problematic. 
The use of HSA as the formulation matrix would make detection of crystallinity by DSC 
difficult due to the low denaturation temperature of the protein matrix. While SEM has 
been used in accelerated stability studies of amorphous formulations,26,27 several 
limitations complicate its application toward the analysis of bulk NAB PTX. As a surface 
characterization tool, the use of SEM for monitoring crystallization is generally limited to 
crystallization events taking place on the formulation’s exterior or within a thin film, 
making characterization of a powdered, bulk material more difficult.  
With detection limits for crystallinity approximately an order-of-magnitude lower 
than mentioned above, SSNMR has been used to quantify and characterize crystalline 
content within a variety of powdered samples.30–33 SSNMR characterization of NAB PTX 
was previously performed in the course of patent litigation (Elan Pharma International 
Ltd. v. Abraxis BioScience Inc., United States District Court for the District of Delaware) 
in 2008.34,35  
Nonlinear optical (NLO) microscopy, in particular second harmonic generation 
(SHG), has recently emerged as a complementary technique for the rapid detection and 
quantification of trace crystallinity within pharmaceutical materials.36–41 Coherent SHG 
selectively arises exclusively from the bulk crystalline fraction and only within crystals of 
appropriate symmetry. The chirality inherent in most new pharmaceutical APIs largely 
guarantees that the crystals produced will be bulk-allowed for SHG. This selectivity for 
30 
 
crystalline API has allowed measurements with detection limits on the order of parts per 
billion to as low as parts per trillion ranges under favorable conditions.42   
Despite the low detection limits of SHG microscopy, the SHG intensity itself 
provides little significant chemical information about the composition of the SHG-active 
source. In the present study, efforts were undertaken to lower the detection limits of 
Raman spectroscopy through targeted analysis guided by SHG imaging. In brief, 
targeting Raman analysis to regions of interest pre-identified by SHG minimizes the 
volume of additional material that must be probed in conventional chemical imaging 
modalities.   
In the present study, assessment of this SHG-guided analysis approach was 
performed for the amorphous IV formulation Abraxane® (nanoparticle albumin bound 
paclitaxel for injectable suspension). Abraxane® was the first nanosuspension approved 
for clinical use13,16 and is indicated to contain 10% (w/w) paclitaxel (PTX) bound to 
nanoparticles of human serum albumin (HSA). Abraxane® has been shown to have 
increased efficacy compared to other PTX formulations (e.g., Taxol®), particularly in the 
treatment of breast cancer,16,43,44 non-small cell lung cancer,45–48 and pancreatic 
carcinoma.49 PTX is generally regarded as exhibiting substantial solubility limitations, 
with crystalline PTX  exhibiting poor bioavailability.13 In addition to the increased 
apparent solubility arising from an amorphous nanosuspension, it is thought that 
Abraxane® achieves higher treatment specificity as a result of its HSA matrix, utilizing 
the known high protein uptake rate of tumors.20,50–52  
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3.2 Materials and Methods 
Abraxane® samples were analyzed in their native (solid) form as obtained from 
the manufacturer. Four different batches were imaged (lot numbers: 6106359, 6106934, 
6107014, and 6107321, batches 1-4 respectively). SHG images were acquired with a 
commercial SONICC (second-order nonlinear optical imaging of chiral crystals) 
microscope (Formulatrix, Inc.). The system contains a Fianium FemtoPower laser (1060 
nm, 1.3 W power output), with a 51 MHz repetition rate and a 166 fs pulse width. The 
instrument uses resonant mirror/ galvanometer beam scanning (8 kHz fast axis) to 
generate images. Unless otherwise stated, all SONICC images were acquired with 250 
mW infrared (IR) power at the sample, with a 2 second image acquisition time. SHG 
light was collected in the transmission direction, requiring the preparation of thin samples 
to minimize scattering losses. In brief, samples were prepared by placing a small aliquot 
of powder between two glass coverslips, within a thin (~100 m) spacer to ensure 
uniform sample thickness.53 12 fields of view were obtained for each sample and used to 
generate particle histograms. The fraction imaged by SHG represents approximately 1% 
of the 1 g bulk sample, and a total volume probed of 2.2 mm3 (12 fields of view with 
dimensions of 1925 m x 1925 m x 50 m). For analysis of relative PTX crystallinity in 
batch 1, physical mixtures of crystalline PTX in HSA (Attix Pharmaceuticals) (0.1% - 
5% drug loading) were prepared as standards for a calibration curve. Given the 10% 
(w/w) loading of PTX in Abraxane®, these standards correspond to 1% - 50% relative 
crystallinity of the PTX. While it is possible the PTX used to create the calibration curve 
standards differs in crystal form from the PTX present within Abraxane®, the two most 
common hydrate crystal forms listed in the Cambridge Structural Database (i.e., 
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neglecting non-aqueous solvates) are of the same crystalline space group with nearly 
identical lattice constants. Among crystals of identical building blocks, the average 
observable SHG intensity is dictated primarily by the crystalline space group. In the case 
of these two hydrates (entry IDs RIGLAW and RIGKUP), the average observable SHG 
intensities are assumed to be identical. 
Raman images were acquired on an alpha300 AR commercial confocal 
reflectance Raman microscope (WITec) with a 633 nm HeNe source, 35 mW output 
(Melles Griot). A 10x objective (0.25 NA) was used, giving a beam waist of 0.8 m and a 
depth of field of 20 m. WITec Control 1.60 was used for data collection. Specific fields 
of view (300 m x 300 m) containing a region of interest within the bulk powdered 
sample were first located via SHG, and then marked for subsequent confocal Raman 
analysis. With the crystalline domain located at the center of the marked 300 m x 300 
m field of view (FOV), re-positioning on the Raman microscope via bright field 
imaging was quite reproducible, allowing the crystallite to be located via spectral analysis 
with minimal searching. Each spectrum was acquired with four minute integration time, 
followed by high-pass digital filtering to remove fluorescence background. Bench top 
powder X-ray diffraction (PXRD) was acquired on a Rigaku SmartLab™ diffractometer 
(0.1544 nm wavelength) scanned at one degree/min.  
3.3 Results and Discussion 
  Figure 1 shows SHG images of four different batches (varying lot 
numbers) of Abraxane®. Samples were imaged in powdered form, as received from the 
manufacturer. All images are shown on the same brightness scale. Insets show line scans 
33 
 
across a single particle in each batch in units of megacounts per second (Mcps). High 
variation in crystallinity and particle number/ size between batches is readily observed.  
A sample from batch 1 was imaged with SHG both before and after dissolution in 
ultrapure water, the results of which are shown in Figure 2. This experiment was 
performed primarily to exclude possible SHG interferences from the relatively small 
fraction of buffer salts known to form noncentrosymmetric and therefore SHG-active 
crystals.54 It would not be unreasonable for salts to exist within the formulation given the 
use of HSA as the matrix. However, all such compounds are highly water soluble and 
would not be expected to remain following addition of water to the sample. Furthermore, 
solubilization in water mirrors the recommended procedure in preparation for parenteral 
introduction. Figure 2 summarizes these results, showing a bright field image of 
Abraxane® in the solid state (2a), bright field and cross-polarized images of individual 
crystallites within Abraxane® suspension (2b) and SHG images of solid-state and 
suspended Abraxane® (2c and 2d, respectively). SHG active areas remained even after 
dissolution in ultrapure water combined with vigorous mixing, suggesting that the SHG-
active material exhibited poor aqueous solubility and was unlikely to be an SHG-active 
buffer salt. Additionally, these crystallites are likely to remain un-solubilized within 
Abraxane® suspension. 
Additional confocal Raman measurements were performed selectively on the 
regions of interest identified as the SHG-active domains in the native Abraxane® dosage 
form, the results of which are summarized in Figure 3.  With initial screening by SHG, a 
crystalline domain of interest (~20 m diameter) within a 300 m x 300 m FOV was 
marked for subsequent analysis, shown in Figure 3a.  Figure 3b summarizes the 
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experimental Raman spectra acquired within the region of interest and elsewhere in the 
FOV. For comparison, the experimental Raman spectra of pure PTX and pure HSA are 
also shown. The Raman spectrum acquired from the SHG-active region of interest agrees 
remarkably well with the measured spectrum of pure crystalline PTX. Furthermore, the 
peak heights were notably greater in the SHG-active region, consistent with a higher local 
concentration of PTX relative to other locations within the formulation. In addition, the 
two peaks at 1007.1 cm-1 and 1604.3 cm-1 are most pronounced in the crystalline PTX 
spectrum, as well as in that of the SHG-active region, but are only marginally detectable 
in other locations within the formulation. 
If the SHG-active and poorly soluble fraction of material in Abraxane® is 
attributed to PTX, SHG microscopy can be used to estimate the relative crystallinity of 
the active ingredient within the formulation. A calibration curve of SHG signal was 
constructed from physical mixtures of crystalline PTX in HSA at various loadings, 
accounting for the 10% (w/w) loading of PTX in Abraxane®. The PTX within batch 1 
was found to be 30  13% (95% CI) crystalline, corresponding to 3.0% overall 
crystallinity in the measured lot of Abraxane®. The relatively large uncertainty in the 
crystallinity arose primarily from the limited volumes of materials probed, resulting in 
statistical fluctuations in the crystalline fraction per probed volume.  Such a large fraction 
of PTX present in a crystalline state may potentially impact the effective dose of the 
formulation. Analysis by PXRD failed to show any peaks, consistent with these relatively 
low levels of crystallinity. A representative PXRD pattern is shown in the supporting 
information, Figure SI-2. 
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The spatial information afforded by SHG also allows assessment of the size 
distribution of poorly soluble particulates in situ within the final dosage forms. 
Histograms of SHG-active particle sizes are shown in Figure 4 for batches 1, 3, and 4 (4a 
– 4c, respectively) as batch 2 did not contain enough particles to produce a meaningful 
histogram. From these results, different lots exhibited diverse distributions, with particle 
size ranging from <10 m to over 120 m. As the mass fraction probed by SHG 
represents approximately 1% of the container contents, the observation of 37 particles 
greater than 26 m within the imaged fraction of batch 1 suggests approximately 3700 
(600) particles > 26 m present within the final dosage form, with the determined 
standard deviation based on Poisson statistics. This degree of direct access to the size 
distribution of insoluble crystalline particles would be challenging to obtain in situ within 
the solid-state final dosage form using alternative standard methods given the optical 
opacity of the Abraxane® formulation, but is reasonably straightforward to access by 
SHG imaging. This initial screening by SHG greatly reduced the time required to perform 
the Raman measurements.  For a typical line-scan commercial Raman imaging approach, 
the laser power required to obtain the SNR present in Figure 3 for a 256 pixel laser line 
would be approximately 9 watts. In the assumption that this power does not represent a 
laser-limited measurement, and decreasing the per pixel integration time to 30 seconds 
(acceptable minimum SNR for identification), it would take approximately 8 hours of 
continuous data acquisition to map out a given field of view with equivalent (512 x 512) 
resolution, compared to 2 seconds/ FOV used for the SHG images. This represents a 
reduction in the measurement time of over 2 orders of magnitude. It is further of note that 
the SNR present in these SHG images (~500 for the line scan in Figure 1a) could be 
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equivalently reduced, decreasing the required measurement time well into the video-rate 
regime.  
3.4 Conclusions 
Using SHG microscopy to identify regions of interest within an amorphous 
pharmaceutical formulation was found to enable targeted analysis by Raman 
spectroscopy. By guiding Raman measurements to only these regions of interest, the 
measurement time was reduced by over 2 orders of magnitude relative to established 
bench top instruments. Characterization of the amorphous nanosuspension Abraxane® 
illustrated this process for a drug formulation currently in clinical use. Substantial 
variability in relative crystallinity was observed within the product as-received, with 
water-insoluble particles up to 120 m observed in the formulation.  SHG-guided 
analysis by Raman spectroscopy was consistent with crystalline paclitaxel comprising the 
poorly soluble particles. These combined results illustrate the potential benefits provided 
by the marriage of the rapid and highly selective technique of SHG with information-rich 
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Figure 3.1 SHG images of batches 1-4 (A-D, respectively) of Abraxane®. Insets show 
line scans across an individual crystalline domain for each image, in units of millions of 
counts per second (Mcps). All images are shown on the same brightness scale. Large 






Figure 3.2 Bright field, cross-polarized, and SHG images of Abraxane® before and after 
suspension in ultra-pure water followed by rigorous mixing. (A) Bright field image of 
lyophilized Abraxane® powder. (B) i) and iii) Bright field images of individual 
crystallites after suspension, ii) and iv) cross-polarized images. (C) SHG image of 
lyophilized Abraxane® powder. (D) SHG image after suspension. Results show that 
SHG active regions exhibit poor aqueous solubility. These results indicate that the SHG 





Figure 3.3 SHG image of Abraxane and corresponding confocal Raman spectra after 
digital high-pass filtering. (A) SHG image. (B) Raman spectra. The blue and red traces 
shown in (B) were taken at the indicated locations of regions I and II, respectively. For 
comparison, the black and green traces show the experimental spectra of pure PTX and 
pure HSA (blank), respectively. Experimental spectra for pure PTX and for SHG active 
domains in Abraxane® agree well. High SNR present at 1007.1 cm-1 and 1604.3 cm-1 
within these two spectra are consistent with higher local PTX concentration within an 





Figure 3.4 Histograms of crystal size for batches 1,3, and 4 of Abraxane® (A-C, 
respectively) with occurrence reported as particle number density. Not enough crystallites 
were present in batch 2 to produce a meaningful histogram. Insets show higher size 
ranges. Crystals up to 120 m are present in Abraxane®, with substantial variability in 







CHAPTER 4. PARTS PER MILLION POWDER X-RAY DIFFRACTION 
4.1 Introduction 
 The chemical complexity of emerging drug molecules is rapidly increasing, 
driven by the desire for more potent drugs with higher specificity and fewer side effects. 
However, the growing chemical complexity presents challenges in developing 
formulations that retain sufficient bioavailability. As a result of increased chemical 
complexity, approximately 80% of potential active pharmaceutical ingredient (API) 
candidates are in danger of being abandoned due to poor systemic exposure.1–3 APIs are 
typically required to be sufficiently hydrophobic to pass through cell membranes and 
enter the bloodstream to reach their targets. However, the hydrophobicity must be 
balanced by a sufficiently high aqueous solubility. As the size and complexity of the API 
increases, these mutually exclusive properties become increasingly difficult to 
simultaneously satisfy.  
Amorphous APIs are an attractive option for increasing the bioavailability of 
poorly soluble APIs through the development of formulations containing higher free 
energy solid state forms, with correspondingly faster dissolution rates.3–10 However, 
amorphous APIs are typically metastable, with the potential to crystallize over timescales 
that vary considerably from compound to compound, with external conditions such as 
temperature and relative humidity, and with the matrix or formulation in which the API 
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resides.11–14 Several strategies have been utilized to stabilize amorphous formulations, 
including the use of polymeric crystallization inhibitors to form amorphous solid 
dispersions (ASD), as opposed to amorphous API powders.6,7,15,16 Nevertheless, major 
challenges emerge in assessing the long-term stability of amorphous formulations, 
particularly for low API loadings and early stages of crystal formation. Underpinning all 
of these formulation efforts is the need for sensitive, precise, and accurate analysis tools 
for characterizing API crystallinity, particle size, and spatial distribution within 
formulations, since each of these parameters can affect the release profile.  
The most widespread current approaches used for assessing crystallinity in APIs 
and API formulations include powder X-ray diffraction (PXRD),16,17 differential scanning 
calorimetry (DSC),16 scanning electron microscopy (SEM),17–20 and spectrochemical 
techniques such as Raman.17–26 However, each of these techniques faces significant 
practical limitations in characterizing the spatial distribution of APIs, the characteristic 
domain sizes, and even the presence or absence of crystallinity. The detection limits for 
PXRD are typically on the order of a few percent crystallinity by mass. Similar detection 
limits are generally observed for DSC, Raman, electron microscopy, and solid state 
NMR. Currently the detection limits for percent crystallinity range from 0.2-5% for 
existing methods. These limits can be problematic in studies of amorphous formulations 
for which the total drug loading within an amorphous matrix may only be a few percent. 
Recently, brighter X-ray sources from synchrotron facilities have been utilized as one 
route for improving the detection limits of PXRD. Efforts using synchrotron X-ray 
sources for powder diffraction have lowered the limits of detection for trace crystallinity 
of APIs to approximately 0.2% crystallinity.27  
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Second harmonic generation (SHG), or the frequency doubling of light, is particularly 
well-suited for quantitative analysis of API formulations for several reasons. Firstly, the 
symmetry requirements for even ordered nonlinear processes requires SHG to be highly 
selective for noncentrosymmetric crystals, with negligible background contribution from 
amorphous materials.28 The inherent chirality in most emerging APIs guarantees that the 
resulting crystals will satisfy the symmetry requirements for SHG. Secondly, SHG shares 
the same advantages as two-photon excited fluorescence by allowing imaging in turbid 
media, as only the “ballistic” unscattered light surviving to the focal volume contributes 
to the detected signal. Lastly, SHG exhibits a high intrinsic dynamic range of detection, 
allowing quantification spanning ppm levels through 100% crystallinity. Previous studies 
of model systems have suggested detection limits on the order of ppm for crystallinity 
within amorphous solid dispersions.29–32 
Despite the demonstrated capabilities of SHG for quantitative analysis in 
amorphous pharmaceutical formulations, the nature of the signal provides little 
qualitative information on unknowns. Many pharmaceutical formulations contain a 
multitude of ingredients that can potentially produce SHG-active crystalline materials. 
However, the SHG intensity alone is a relatively information-poor indicator for 
composition within the crystalline components. Furthermore, reliable quantitative 
analysis by the SHG intensity has previously required prior calibration on a material-
specific basis. As a result, methods that can provide qualitative determination of 
crystalline composition at trace (ppm) levels would significantly improve the broader 
utility of SHG for analysis of amorphous pharmaceutical formulations. Orthogonal 
analyses at these low levels of crystallinity present their own analytical challenges. The 
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following article describes a method capitalizing on the complementary capabilities of 
SHG and XRD to yield crystallinity detection limits in the ppm range by XRD. By using 
an SHG microscope to guide targeted XRD analysis, the detection of crystalline materials 
can be achieved for samples that are deemed amorphous by conventional bench-top 
PXRD analysis. 
4.2 Materials and Methods 
  A combined instrument for SHG and XRD in a single, integrated platform has 
been described in detail previously.33 Briefly, the SHG microscope was integrated into 
GM/CA@APS beamline 23-ID-B at the Advanced Photon Source, Argonne National 
Laboratory. The unattenuated photon flux for a 12 keV, 5 µm diameter beam using the 
minibeam collimator34 was 1.5 x 109 photons/sec/µm2. The SHG microscope utilized a 
FemtoPower 1060 laser (Fianium) with a repetition rate of 50 MHz, pulse width of <150 
fs, and power at the sample of ~90 mW. The laser was focused to a spot size of 2 µm 
with a 20 µm depth of field by a 10x objective with a numerical aperture of 0.35 (Optem, 
28-21-10). The SHG signal was separated from the fundamental by a series of dichroic 
mirrors (Semrock FF555-Di03-25x36, Chroma z1064rdc-sp) and filters (Chroma 
HQ530/30m, and CVI, 03FCG567/KG3), and detected using photon counting modules 
(Hamamatsu, H10722-10). Beam scanning was achieved by use of an 8 kHz resonant 
scanning mirror (Cambridge Technology, 1-003-3002509) moving along the vertical (y) 
axis and a galvanometer stepping mirror (Cambridge Technology, 6210H) moving along 
the horizontal (x) axis to generate images with a 300 x 300 µm field of view and a 2 µm 
pixel size. All SHG images were integrated for 1000 sweeps per line (~20 sec/image). All 
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software for the scan mirror control and data acquisition was written in-house. The 
general workflow for the SHG-guided XRD analysis is shown in Figure 1.  
The diffraction patterns were analyzed and indexed by the software packages 
Fable and GrainSpotter.35 The positions of the diffracted peaks are retrieved frame by 
frame based on a single intensity threshold and combined into a g-vector file.  The g-
vector file stores the peak positions in 3D coordinates, where individual frames are sitting 
in the x-y planes with the tilt angles in the third dimension. GrainSpotter then generated 
numbers of theoretical diffraction patterns based on the reported Ritonavir (RTV) crystal 
structure among the different crystal orientations and built a lookup table for indexing. A 
built-in algorithm automatically matched the peaks in the g-vector space with the lookup 
table and reported the crystal orientation when it found an overlay in good agreement 
with the observed experimental diffraction pattern. Once the crystal orientation was 
obtained, the theoretical diffraction patterns at this particular orientation were generated 
by the PolyXSim and compared with the experimental data.1D powder-type patterns are 
recovered via azimuthal autocorrelation (i.e., along a constant radius, or 2θ value) of the 
2D image. As only discrete spots are present in these images, integrating or averaging 
along this dimension artificially diminishes the observed SNR for these reflections. 
Rather, autocorrelation preserves the 2θ locations and intensities of individual reflections 
while removing the amorphous scatter arising from the glass substrates surrounding the 
sample.  
The physical mixture of 100 ppm ritonavir (Astrix Labs, India) in hydroxypropyl 
methylcellulose (Shin Etsu, Japan) was prepared via serial dilutions with geometric 
mixing. Portions of each sample were then sandwiched between two number 1 coverslips 
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to achieve a uniform sample thickness of ~150 µm, with two coverslips serving as 
spacers on either end. The coverslips were then mounted on the goniometer for combined 
SHG and XRD analysis. Ritonavir was chosen as a representative model system, in part 
because it exhibits mid-range SHG activity compared to a suite of small molecule APIs36 
and the polymorphic purity of the commercial product is well established.37 The ritonavir 
was used as received from the manufacturer. 
SHG imaging for assessment of overall crystallinity was performed on a system 
described in detail previously.38 Each of 110 fields of view were comprised of multiple 
images corresponding to adjacent planes in the z direction (i.e., parallel to beam 
propagation), with each plane integrated for approximately 2 seconds at a laser power of 
50 mW. Post-acquisition, the in-focus plane from each field of view was isolated for 
analysis. NIH ImageJ was used to threshold each representative plane and assess particle 
number and size.39 
4.3 Results and Discussion 
 Particle sizing and counting was performed on a large (>100) set of SHG images 
to independently quantify the level of crystallinity within a physical mixture (PM) of 
RTV in hydroxypropyl methylcellulose (HPMC). Figure 2a and 2b show two 
representative SHG images of 100 ppm (w/w) RTV in HPMC. Figure 2c shows a 
histogram of particle volumes for the pooled data set.  
 Comparisons of the SHG active volumes to the total probed sample volumes can 
be used to provide estimates of the overall crystallinity present with the physical mixture. 
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An overall crystallinity of 230 ppm (v/v) was recovered for the imaged fraction of the 
100 ppm (w/w) PM.  
 While the recovered crystallinity by SHG differs from the expectations based on 
gravimetric analysis by approximately a factor of two, several potential sources of error 
could account for this difference. First, the PM was prepared as 100 ppm by weight. 
However, using the SHG images to estimate the crystallinity produces an estimate by 
volume. Second, the relative densities and packing densities of both RTV and HPMC 
could affect the calculated crystalline content. While the combined effect of these 
variables is difficult to estimate, observed variations in the packing density of HPMC and 
other pharmaceutical excipients suggest that variations in these quantities, in addition to 
the absolute density difference between HPMC and RTV, could introduce sufficient error 
to account for this difference.40,41 Third, although the number density of crystallites 
observed between the >100 raw images suggests a sufficiently wide sampling of the 
powder aliquot via SHG, it is possible this ~mg aliquot is not representative of the ~kg 
bulk PM. Finally, the total volume of material probed by SHG was approximately 0.5 L. 
At a loading (by volume) of 230 ppm, this corresponds to ~100 pL of total crystalline 
material probed. Considering these combined factors and the exceedingly small volume 
of crystalline sample probed, the recovery of a percent crystallinity within 130 ppm of the 
anticipated value based on gravimetric analysis is encouraging for future quantitative 
studies. 
 Prior to combining SHG with synchrotron XRD, diffraction data were acquired 
for a single crystal of RTV across 120 different crystal orientations within the 
diffractometer. Figure 3 illustrates the effect of preferred crystallographic orientations in 
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XRD. Total time required to acquire the full tilt series was 2 minutes per location, with 
another ~2 minutes of total dead time for sample repositioning between exposures. While 
only a fraction of all possible reflections are observed for the single frames (1 degree 
integrations) in Figure 3a and Figure 3b, summation of the diffraction patterns through 
the 120 crystal orientations begins to recover the anticipated PXRD pattern retrieved 
from the Cambridge Structural Database (CSD) (Figure 3c red trace). It is noted that the 
relative peak heights differ from the theoretical pattern from the CSD. This observation is 
expected, as only a subset (varying only one rotation axis through 120) of all possible 
orientations is contributing to the summed pattern in Figure 3c (blue trace). 
 From both the raw diffraction data and the pooled results shown in Figure 3, 
preferred orientation effects from a single orientation of the sample can complicate 
analysis by synchrotron XRD, as only a subset of all possible Bragg reflections will 
appear simultaneously if only one or a few orientations from a finite number of 
crystallites are probed in the course of a measurement. Such effects can complicate both 
qualitative chemical identification of a crystal and quantitative determination of volume 
fraction, as both peak location and relative amplitude for a given reflection can vary 
significantly based on the orientation of the crystal. For trace crystal detection, in which 
only a relatively few total number of crystals may be used in the complete analysis, these 
crystal orientation effects are particularly pronounced.  
 In single crystal diffraction analysis, indexing provides a route for effectively 
allowing crystal orientation to be used as an advantage rather than a limitation in 
diffraction analysis. Figure 4b shows the indexing of a zoom-in of the diffraction image 
shown in Figure 4a using the Fable software package.35 Experimental reflections are 
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shown in black, while theoretical reflections for the determined crystal orientation are 
shown in red. The indexing process successfully recovers the known crystal orientation 
across each of the 120 diffraction images, assuming explicitly the lattice constants 
obtained from the CSD (entry ID YIGPIO03). Such an approach suggests the validity of 
indexing to subsequently confirm the identity of a crystal by XRD, after pre-identified for 
analysis by SHG. 
 The combination of SHG microscopy with synchrotron XRD has the potential to 
significantly lower the limits of detection for trace crystallinity within an amorphous 
medium, as demonstrated in Figure 5.  Analysis of the same 100 ppm (w/w) mixture of 
RTV in HPMC, shown in Figure 5, by conventional benchtop PXRD results in no 
significant experimental evidence for the presence of crystallinity (Figure 5c). However, 
through SHG guided synchrotron XRD, the trace crystallinity is readily detected as seen 
in Figure 5b. The diffraction pattern for the region with the greatest signal in the SHG 
image (Figure 5a) is shown in Figure 5b. The anticipated reflection positions based on the 
indexing results and recovered single crystal orientation are also included in Figure 5b 
(solid red spots). The red circles in Figure 5b indicate the areas where the indexing and 
experimental diffraction match. The observed reflections are consistent with the assumed 
lattice parameters for RTV, supporting the ability to characterize crystallinity within a 
trace (100 ppm) crystalline sample by SHG-guided synchrotron XRD. Diffraction images 
of multiple SHG-inactive regions, taken with the identical beam size and exposure time, 
do not show any observable reflections, further suggesting that the observed diffraction is 
unlikely to be arising from the excipient polymer matrix. 
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 SHG-guided diffraction analysis also offers two key quantitative advantages 
regarding the observed signal-to-noise ratio (SNR) in the measurements. The first 
advantage is through background reduction. The rapid identification of crystal location by 
SHG allows X-ray diffraction analysis with a small (10 m) beam. Significant 
background from amorphous scatter is arguably one of the most common factors 
contributing to the relatively high detection limits of traditional PXRD measurements. 
The volume of amorphous material probed is reduced by using the minibeam collimator 
to pair the size of the X-ray source to that of the crystalline sample, resulting in a 
lowering of the background scatter from amorphous contributions.34 The second SNR 
advantage arises from the reduction in spectral congestion. The diffraction features in the 
single-crystal measurements are well separated in angle from other diffraction features, 
while multiple peaks can be highly overlapping in conventional powder XRD.   The 
observed SNR in the diffraction measurements in Figure 5b is ~5000 from a 1 second 
exposure with a 5 µm diameter beam. Given the sixth power dependence of diffraction on 
crystal diameter, this SNR corresponds to a minimum detection limit for a single crystal 
on the order of 2 µm, assuming a 5 µm diameter beam. 
 In addition to the SNR advantage in the X-ray analysis, the integration of SHG 
imaging also offers a significant time savings in the identification of crystalline domains. 
Although in principle, background suppression could be broadly achieved by localization 
of the X-ray source, the relatively long integration time per pixel (1 s in the present 
study) represents a considerable cost. Some time savings can be expected through 
iterations first using a spatially broad source to identify regions of interest based on 
observed diffraction, then progressing to smaller diameter beams for SNR optimization. 
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However, this strategy will be limited to relatively large crystals to overcome the 
background with a wide-area source and can still require several hours of synchrotron 
beam time. By first targeting the diffraction to regions of interest (ROIs) within ~1 µm 
resolution rapidly identified by SHG, high SNR diffraction can be collected in a matter of 
seconds.  
 Although all the measurements reported in this study were performed with an 
integrated instrument combining SHG with synchrotron XRD in a single platform, this 
general strategy for SHG-guided diffraction is not limited to this one architecture. If the 
SHG-active ROI can be reliably and accurately located through the use of any set of 
inherent or artificial fiducial markers, combined measurements could in principle be 
obtained through pre-screening on a benchtop nonlinear optical microscope followed by 
diffraction on an independent beam line. For small crystals, the integrated system has the 
advantage of absolute accuracy in the positioning between SHG and synchrotron XRD to 
within 1 µm. However, for larger crystals off-line analysis may still provide the accuracy 
required for structural characterization.  
 Off-line measurements would also have the advantage of allowing for integration 
with complementary methods for structural analysis, such as Raman spectroscopy. SHG-
guided Raman spectroscopy has recently been used to study a commercial formulation of 
nanoparticle albumin-bound paclitaxel.42 Increasing the number of orthogonal 
measurements of the same sample significantly improves the overall confidence of the 
conclusions drawn, with Raman potentially serving as a relatively simple first-pass 
analysis approach prior to synchrotron XRD. XRD is arguably the gold standard for 
crystal characterization, in many cases showing a more sensitive response to subtle 
55 
 
variations in crystal structure and form than common orthogonal techniques such as 
Raman, DSC, and SEM. The high (>5000) SNR observed in the diffraction images of 100 
ppm RTV in HPMC illustrate these advantages. Additionally, the detector integration 
time required for thorough characterization of crystal form by synchrotron XRD (<< 1 
second) is significantly lower than that required for the Raman measurements performed 
in the previous study (on the order of several minutes). As construction of new 
synchrotron facilities continues worldwide, the overall availability and utility of SHG-
guided XRD has the potential to increase concurrently. 
The generalizability of this technique can be assessed from previous 
measurements done using bench-top instrumentation. The integrated diffraction for any 
small molecule organic API crystal is likely to be similar, with much greater anticipated 
variability in the SHG activity.  Fortuitously, previous experiments have shown a 7 orders 
of magnitude detectable dynamic range for the observed SHG intensity of 42 different 
APIs under comparable imaging conditions.36 The SHG activity of RTV falls in the mid-
range of this scale, suggesting viable detection for the majority of homochiral crystalline 
APIs. From previous studies of common excipients, it is reasonable to suggest that the 
approach described herein will have few constraints arising from the selection of polymer 
matrices in amorphous solid dispersions. From these combined results, it is reasonable to 
suggest that SHG-guided micro-diffraction is likely to be a broadly applicable approach 






 SHG microscopy and synchrotron XRD were coupled to detect trace crystallinity 
of an API in a common formulation excipient. The combined instrument was able to 
detect 100 ppm (w/w) ritonavir in HPMC, decreasing the limit of detection by more than 
1 order of magnitude over previously reported values.27 Using SHG to guide synchrotron 
XRD analysis provides two main advantages over PXRD. First, SHG allows for rapid 
detection and localization of areas containing crystalline APIs. The SHG images can be 
acquired in a matter of seconds, whereas the same field of view would be prohibitively 
time-consuming to image via XRD raster scanning. Secondly, SHG-guided diffraction 
allows background suppression in the XRD through the use of a 5 µm diameter source 
better matched to the dimensions of the crystalline domains.  Such low detection limits 
have the potential to enable substantially faster turn-around times in optimization of 
amorphous solid dispersions, in which even trace crystallinity can substantially impact 
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Figure 4.1 Experimental work-flow for SHG-guided synchrotron XRD analysis of trace 
crystallites. First the amorphous solid dispersion is imaged using an IR source. The 







Figure 4.2 SHG images and generated histogram of particle volumes for 100 ppm 
ritonavir in HPMC. (A) and (B) SHG images. (C) Recovered histogram. The SHG-active 






Figure 4.3 Single crystal diffraction patterns for Ritonavir. Diffraction patters were 
obtained for 120 different angles with representative diffraction patterns from two 
different angles shown in A and B. A simulated powder diffraction is obtained by 
summing all of the single diffraction images together (blue trace in C) and compared to 
the predicted powder pattern obtained from the CSD (red trace in C). Even though the 
experimental pattern was obtained from only a small subset of crystal orientations it is 






Figure 4.4 Results of diffraction indexing for Ritonavir. A) Single crystal diffraction 
pattern for ritonavir. B) Single crystal diffraction pattern generated by the Fable software 
suite based only on lattice parameters from the CSD entry for Ritonavir (red dots, 
overlaid). Excellent agreement is observed between experimental and theoretical 
diffraction patterns indicating that the indexing method can correctly recover single 









Figure 4.5 Analysis of a 100 ppm sample of ritonavir in HPMC (0.01% w/w) with 
SHG-assisted synchrotron XRD. Where a) is epi-SHG signal from ritonavir, with the red 
crosshairs denoting the center of the synchrotron X-ray beam. An XRD pattern of the 
SHG active region (circled in yellow) is shown in b along with the results from the auto 
indexing (red dots). Areas where the auto indexing results and experimental diffraction 
pattern agree are highlighted by the red circles. The powder XRD spectrum using a 
conventional PXRD benchtop is shown in c and indicates that the sample is amorphous 





CHAPTER 5. POLARIZATION-MODULATED SECOND HARMONIC 
GENERATION ELLIPSOMETRIC MICROSCOPY AT VIDEO RATE 
5.1 Introduction 
 The information content of NLO microscopies such as SHG can be enhanced 
through the recovery of Jones tensor elements via polarization-dependent measurements. 
The Jones tensor for SHG describes the relative efficiency of frequency doubling given 
defined polarizations (horizontal or vertical, “H” or “V” respectively) for the two incident 
photons (frequency ) as well as the exiting photon (frequency 2).1 For SHG, in which 
the two incident photons are indistinguishable, this yields 6 total Jones tensor elements 
for a given sample. As these Jones tensor elements should vary with changes in structure 
and orientation of the sample, recovery of these parameters yields new information 
potentially inaccessible by traditional measurements relying only on recovery of the 
integrated intensity. Polarization-dependent SHG measurements have seen a rich history 
in a variety of analyses, including characterization of collagen2–4 and cell membranes,5 as 
well as analysis of tissues in disease diagnosis and monitoring.6–10 Polarization-dependent 
SHG measurements have also been used for characterizing inorganic materials,11–13 
protein crystals,14 and surfaces/ monolayers.15,16 
 Unfortunately, the majority of previous instruments for polarization modulation in 
NLO microscopies have relied on the manual rotation of optical elements (e.g., wave-
plates, polarizers) for modulation of the incident field and polarized detection of the 
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exiting field.15,17 Such architectures generally yield long data acquisition times, as 
acquisition of complete data sets requires repeated imaging at a large number of optical 
element rotations. Such approaches are not compatible with in vivo imaging or high-
throughput measurements, in which complete image acquisition must be accomplished at 
or near video rates for practical implementation. A number of previous strategies have 
sought to increase imaging frame-rates in polarization-dependent NLO microscopies. 
Stoller et al3 used polarization modulation at 4 kHz together with sample scanning to 
image collagen assemblies in rat tail tendon. Tanaka et al18 used an electro-optic 
modulator to cycle between two fixed incident polarizations. Lien et al19 demonstrated 
the use of a liquid crystal modulator (~kHz frequencies) in SHG imaging. Unfortunately, 
most of these past approaches still require at least several seconds of integration time per 
frame, with acquisition times up to several hours per frame. Additionally, none of these 
previous efforts recover Jones tensor elements for the sample, but rather often utilize 
multivariate or fourier transform (FT) based analyses. The ability to recover sample 
tensor elements at video rates in NLO microscopies could be a powerful new technique 
for tissues analysis, high-throughput structural characterizations, and fundamental studies 
of NLO theory and materials. 
 Rapid (8 MHz) polarization modulation via an EOM, combined with synchronous 
digitization (SD) has enabled recovery of Jones tensor elements in SHG microscopy at up 
to 15 Hz frame rates. Recovery of these Jones tensor elements is termed nonlinear optical 
Stokes ellipsometry (NOSE). Following characterization of the EOM response for 
recovery of the incident polarization states, validation of the system was demonstrated 
through recovery of the Jones tensor elements for Z-cut quartz at a well-defined 
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orientation. Polarization-dependent imaging at video rates is then demonstrated with a 
sample of naproxen microcrystals. Finally, polarization-dependent SHG images are used 
to identify twinning in a crystal of the protein glucose isomerase. These combined results 
demonstrate the utility of video rate NOSE in a variety of application spaces. 
5.2 Theoretical Foundation 
The relationship between the detected intensity and a modulated incident 
polarization state in NOSE has been described in detail in previous works15,17,20 and is 
briefly summarized herein. In linear optics, polarization states and optics can be 
described in terms of well-established Jones vectors and Jones matrices, respectively. 
Examples of this mathematical framework are given in Tables 5.1 and 5.2. Recently, this 
framework has been extended to introduce the concept of Jones tensors as polarization 
transfer tensors.21,22 By analogy with Jones matrices, knowledge of the Jones tensor 
allows one to predict all polarization-dependent observables of a given measurement as a 
function of the incident polarization state or states. In this framework, the Jones matrix 
for the EOM rotated an angle  is given by the following expression. 
    
 















       
  5.1 
 The time-dependent phase shift of the EOM, (t), is in turn sinusoidally 
modulated. 
    0sin 2t A f t B       5.2 
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In Eq. 2, A represents the amplitude of modulation, f0 is the modulation frequency in 
cycles/s,  is the phase shift between the driving sinusoidal function and the experimental 
phase of the EOM, and B is the constant residual phase shift inherent in the EOM.  
We have previously derived expressions relating the Jones tensor elements to the 
intensity of n-polarized SHG where n is either v or h for vertical or horizontal 
polarization, respectively.15,17,20 
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  5.4 
In the above equation, the -terms indicate individual elements from the 2×2×2 (2) Jones 
tensor. From this above equation, it is clear that the measured intensity can generally 
recover up to 5 unique parameters ultimately dependent on three nonzero tensor 
elements, which in general are complex-valued. Since the number of real and imaginary 
unknowns exceeds the number of observables by one, only the relative phase between the 
tensor elements can be recovered, which is similar to conventional ellipsometry 
performed for surface analysis. Far from resonance and in the absence of birefringence in 
the sample, B and D are zero-valued, reducing the number of observable down to three, 
paired to the number of unique elements within the Jones tensor for a given polarization 
state of detection.  
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In practice, it is often more convenient to perform the linear fitting to an 
alternative set of Fourier functions. Conversion from the polynomial to Fourier 
coefficients is performed through simple matrix multiplication. The use of Fourier 
coefficients also provides direct comparison with alternative measurements performed by 
lock-in detection.3 In this framework, the detected intensity is described by the following 
analytical expression.  
          2det cos 2 cos sin sin 2I a b c d e             5.5 
Interconversion between the two sets of coefficients can be achieved by simple matrix 
multiplication. 
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  5.6 
An analogous framework can be used to describe the polarization-dependent 
transmittance of the incident infrared beam, which in turn provides information on the 
sample birefringence. In brief, the intensity of the transmitted beam under the conditions 
identical to those used for the SHG measurements is given by the following expression. 
      det cos sinI a b c         5.7 
From Eqs. 5 and 7, it should be clear that the detected response will generally 
exhibit amplitude and phase terms for both the fundamental and second harmonic in , in 
addition to a constant term. However,  is itself sinusoidally modulated in time. As a 
result, direct recovery of the Fourier coefficients from the -dependent intensity is 
straightforward, but analogous quantitative analysis based on the harmonics of f0 from the 
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time-dependent intensity with sinusoidal modulation is not trivial. Previous early efforts 
have addressed this challenge by using sawtooth modulation that is linear in time.3 
However, this strategy is challenging to implement at high speeds because of the much 
larger bandwidth required to drive sawtooth modulation at MHz frequencies relative to 
sinusoidal modulation. In the present case, the use of a resonant tank circuit significantly 
increased the amplitude of modulation (which can be challenging at radio frequencies) 
and improved the stability through bandwidth reduction, but was fundamentally 
incompatible with sawtooth modulation.  
The preceding treatments are valid within the paraxial approximation consistent 
with low numerical aperture lenses and objectives as used in the present study. However, 
it is relatively straightforward in principle to extend this mathematical framework for 
polarization analysis to high numerical aperture objectives in which the electric field has 
projections along all three spatial coordinates, as detailed explicitly in previous work.21 In 
brief, the matrix-notation for propagation of the electric fields as presented in the present 
study allows the influence of tight focusing to be incorporated through multiplication by 
an additional “local field” matrix. This additional matrix relates the incoming and exiting 
local fields experienced within the focal volume to the far-field polarization state detected 
in the laboratory frame. Consequently, the present polarization modulation approaches 




5.3 Materials and Methods 
5.3.1 Instrumentation 
SHG and laser transmittance imaging was performed on a custom microscope 
adapted from an instrument described previously13,23,24 and shown schematically in 
Figure 1. Briefly, an 80 MHz 100 fs MaiTai Ti:sapphire laser (SpectraPhysics) tuned to 
800 nm was used as the incident light source for both SHG and laser transmittance 
imaging, with average powers between 20-220 mW. The beam was scanned across the 
sample using a resonant scanning mirror at 8 kHz (EOPC) synchronized to the laser and a 
galvanometer mirror (CambridgeTech) in the fast and slow axes, respectively. The beam 
was passed through an EOM rotated 45o from its fast-axis. A Soleil-Babinet compensator 
was placed after the EOM to correct for polarization changes induced by the rest of the 
beam path and microscope components. The beam was then directed through a telecentric 
lens pair and square aperture to block the turning points of the sinusoidal resonant mirror 
trajectory. The scanned beam was focused onto the sample with a 10X , 0.3 NA objective 
(Nikon). SHG and fundamental light were separated using a dichroic mirror and collected 
in the transmitted direction. The SHG signal was separated into its horizontal and vertical 
components with a Glan-Taylor polarizer, which were detected on two photomultiplier 
tubes (PMTs) (Hamamatsu H12310-40) with bandpass filters (HQ 400/20m-2p; Chroma 
Technology) to further reject the fundamental. The transmitted fundamental light was 
detected with a photodiode (Thorlabs DET-10A) after passing through a Glan-Talyor 
polarizer set to pass horizontal, allowing for simultaneous polarized laser transmittance 
imaging and SHG imaging. 
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5.3.2 Data Acquisition 
Data acquisition was performed using SD.24 A schematic of the synchronous 
timing control required for SD is depicted in Figure 1. Two PCIe digitizer cards 
(AlazarTech ATS-9350) were used to flash digitize the SHG and laser transmittance on 
three channels synchronously with the laser. Custom software was designed to record 
digitized voltages as 32-bit numbers. The 80 MHz signal from the laser’s internal 
photodiode was used as the master clock. The laser clock was sent through a custom 
timing module, where it was amplified, shifted, and divided by 8, to produce a 10 MHz 
square wave. The synchronous 10 MHz signal was sent to the onboard 10 MHz phase-
locked-loop of the digitizer card, and the digitizer card was set to digitize at 80 MHz 
synchronously with the laser.  
Due to the high Q-factor of the resonant mirrors (Q > 250) amplitude stability was 
achieved at the sacrifice of phase stability. To correct for this drift in phase stability, a 
custom control box was designed and built to perform real-time active phase correction 
of the resonant mirror. The resonant mirror timing box was controlled by an 8-bit 
microcontroller (Silicon Laboratories, C8051f120), running at 80 MHz derived from an 
external 10 MHz phase-lock loop (PLL) synchronous with the 80 MHz master clock from 
the Ti:Sapphire laser, allowing for precise knowledge of the number of laser pulses per 
resonant mirror trajectory. The microcontroller ran a custom built operating system using 
a combination of hardware and software timers to produce the mirror drive signal. The 
feedback of the resonant mirror was analyzed by the box, and corrections to the driving 
phase were made to maintain phase stability of the resonant mirror. Phase corrections 
were performed to a precision of 25 ns, or two clock ticks from the master clock. A 
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monitor output signal from the mirror driver box was sent to the trigger input on the 
digitizer card. A synchronous ramp signal generated by the timing module was used to 
control the galvanometer mirror by incrementing the angle of the mirror after every pass 
of the resonant mirror.  
The signal transients from each individual detector response from every laser 
pulse were digitized synchronously with the laser. A 3-13 ns electronic digital delay stage 
was added between the master clock (10 MHz) signal and the PCIe digitizer cards to 
allow for adjustment of the phase of digitization relative to the signal generation to 
account for the absolute time difference of the clock and the optical path. The resultant 
data were then binned following a sine-wave trajectory, resulting in higher density of 
sampling near the turning points of the trajectory, with the corresponding data analysis 
accounting for this sampling density.  
5.3.3 Polarization Modulation 
Synchronous polarization modulation was performed using a custom-built 
extended length EOM (Conoptics). A third 10 MHz output from the timing module was 
used as an external clock source for a function generator, which was used to generate an 
8 MHz sine wave. The 8 MHz signal was amplified using a high voltage amplifier (AR 
Worldwide KAW1040) combined with a custom built resonant tank circuit and used to 
drive the EOM beyond its half-wave voltage. The period of the resonant mirror was 
carefully chosen using its driver box, so that the number of laser pulses per image was an 
integer multiplier of the number of polarizations used to ensure that each frame began 
with the same starting polarization. For the described experiments, the laser frequency 
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was 80 MHz and the EOM was driven at 8 MHz for a total of 10 unique elliptical 
polarizations. Custom software (Matlab) was developed to separate out each laser pulse 
to generate the 10 polarization-dependent images in real-time. To ensure all 10 
polarizations were sampled in one trajectory of the resonant mirror, pixels were binned in 
the fast-axis to generate images that were 300 by 512 pixels. After acquisition, images 
were resized to 512 by 512 pixels using image interpolation (ImageJ). 
5.3.4 Sample Preparation and Imaging 
Polarization-dependent imaging was performed on z-cut quartz (500 µm 
thickness) at various rotation angles about the z-axis. Images of z-cut quartz were 
acquired with 20 mW average power with 32 frames averaged together. Polarization-
dependent imaging was performed on naproxen recrystallized in isopropanol with 95 mW 
average power. Video rate imaging was performed to generate polarization-dependent 
movies of the sample being translated using an automated sample stage (Prior). Still 
images of naproxen crystals indexed matched in Type A immersion oil were acquired 
with 64 frames averaged. Glucose isomerase was obtained as a crystalline suspension, 
and was dialyzed against 10 mM HEPES, 1 mM MgCl2 and 100 mM HEPES, 10 mM 
MgCl2. The protein solution was concentrated to 26 mg/mL in water and crystallized in 0. 
7 M sodium citrate tribasic dihydrate at pH 7 in 96 well sitting drop crystallization trays 
(Corning). Polarization-dependent imaging of glucose isomerase crystals was performed 
in situ with 225 mW average power and averaged for 2000 frames. Images were acquired 




5.4 Results and Discussion 
 Before the Jones tensor elements for a given sample can be extracted from the 
polarization-dependent SHG images, the polarization state of each laser pulse incident on 
the sample must be characterized. Knowledge of the specific polarization state of the 
incident field requires characterization of the modulation imparted by the EOM according 
to equation 5.2, in which the amplitude, frequency, and phase of modulation, in addition 
to the overall phase relationship between the EOM and the laser repetition rate, all dictate 
the specific polarization state for each laser pulse. Polarized detection of the transmitted 
incident field (in the absence of any sample) allows recovery of the values of  according 
to equations 5.1-5.2 through a least-squares nonlinear fit. Figure 5.2 shows two nonlinear 
fits used to characterize the EOM based on the transmitted laser fundamental (5.2a) and 
SHG from Z-cut quartz, a single-crystal material with well-defined Jones tensor 
elements, at a known orientation (5.2b). The recovered sinusoidal modulation (in time) of 
the EOM recovered from each method in 5.2a and 5.2b is shown in 5.2c, with results 
between the two fits showing reasonable agreement. 5.2d illustrates the probed values of 
delta given the repetition rate of the ultra-fast laser used in the experiments (equally 
spaced points on the y-axis).  
 Although a relatively subtle offset remains between the two calculated phase 
angles (Figure 5.2c), the good overall agreement suggests that the incident polarization 
state can be reliably recovered from measurements of the polarized infrared beam. 
Uncertainties in the parameters A, δ and B from eq. 5.2 were determined through 
numerically calculating the second derivative around the minimum of chi-square space as 
described elsewhere and propagated to determine the standard deviation in the phase 
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values obtained from the fit.25 The values derived from the nonlinear fit for A, δ and B 
were 1.90 ± 0.04, 1.18 ± 0.02 and 1.10 ± 0.02, respectively, and the standard 
deviations for  are all ~± 0.04,  indicated by the error bars shown in Figure 5.2d. 
 Following characterization of the polarization state imparted by the EOM, 
polarization-dependent SHG images of Z-cut quartz were used to confirm successful 
recovery of Jones tensor elements by NOSE microscopy (equations 5.3 – 5.6). After 
linear fitting of the polarization-dependent SHG intensity (function of ) to recover 
Fourier coefficients a-e, equation 5.6 was used to convert the Fourier coefficients to a set 
of polynomial coefficients, which can in turn be used to directly solve for the sample 
Jones tensor elements (equation 5.4). Recovery of Jones tensor elements was completed 
for seven different orientations of Z-cut quartz to establish experimental uncertainties. 
Table 5.3 compares the recovered Jones tensor elements for Z-cut quartz ( one standard 
deviation) with theoretical values.1 Agreement between the experimental and theoretical 
values is observed. The experimental and theoretical values of the Fourier coefficients 
across a variety of Z-cut quartz rotations were also compared. Figure 5.3 shows both 
experimental and theoretical values for both the horizontally and vertically polarized 
detectors for coefficients a and b across 40 different rotation angles of Z-cut quartz. 
General agreement is observed. Departure between the theoretical and experimental 
coefficient values is attributed primarily to uncertainty in the polarization state (), 
imperfections/ birefringence in the Z-cut quartz, and the breakdown of the paraxial 




 Following validation of the method by Z-cut quartz, NOSE images of Naproxen 
microcrystals were acquired to demonstrate 1) the utility of the method for the analysis of 
active pharmaceutical ingredients (APIs) and 2) the use of the Fourier coefficients as a 
complete, concise, and sample-independent method of storing and communicating the 
polarization-dependent SHG response. The specific Jones tensor elements that are non-
zero vary based on the sample lattice symmetry (higher symmetry yields more zero-
valued tensor elements) and orientation, and thus require processing steps that are 
sample-dependent. In contrast, the process of linear fitting to recover Fourier coefficients 
a – e is the same for every sample in the present approach. As the entirety of the 
polarization-dependent information content is contained within these coefficients, they 
provide a complete representation of the measurement. Furthermore, they can be encoded 
into a single image based on a red, green, blue, cyan, magenta (RGBCM) color scale, 
allowing reduction of the dimensionality of a single channel’s response from ten (number 
of unique values of  probed in the course of a NOSE measurement) to one. The process 
of polarization-dependent imaging, linear fitting for coefficients a – e, and RGBCM 
mapping is shown in Figure 5.4. 5.4a represents a traditional SHG image based off the 
total integrated intensity. 8 MHz modulation on the EOM yields 10 unique polarization 
states (5.4b) given the 80 MHz repetition rate of the ultrafast laser used here-in. 
Following linear fitting, the five Fourier coefficients can be assigned a unique color 
(5.4c), where the intensity of each color is directly related to magnitude of the coefficient 
value. Merging these five images into one red, green, blue, cyan, magenta (RGBCM) 
image is shown in 5.4d. Communication of the scales used for color mapping together 
with the RGBCM image allows complete recovery of all polarization-dependent 
78 
 
information probed in the course of the measurement, serving as a convenient starting 
point for exploration of a variety of subsequent data analysis methodologies. 
 Finally, crystals of the protein glucose isomerase were imaged to assess the 
capability of NOSE microscopy for characterizing protein crystal quality. In the field of 
structural biology, multi-domained crystals can complicate solving a crystal structure by 
XRD.26 A means of rapidly assessing overall crystal quality prior to XRD could help 
keep low quality targets from entering time-consuming XRD pipelines. Figure 5.5 shows 
a laser transmittance image (5.5a) of a glucose isomerase crystal. 5.5b uses principal 
component analysis (PCA) of the polarization-dependent images to visualize differences 
in the polarization-dependent response from different domains of the crystal.14 While 
grayscale differences are observed, these differences are arguably accentuated in the 
merged RGBCM color map shown in 5.5c, indicating clearly the presence of twinning in 
this particular glucose isomerase crystal. In addition to providing improved contrast 
between crystalline domains, NOSE microscopy has the distinct advantage of not 
requiring any training of the algorithm as does PCA.  
 It is interesting to compare the NOSE microscope figures of merit to those of 
previous single-point nonlinear optical ellipsometry instruments.17,20,22,27–29 At video rate, 
pixels in the central field of view are sampled with as few as 12 consecutive laser pulses, 
each of which corresponds to one of the 10 possible polarization states produced by the 
EOM. The value of 12 laser pulses represents a minimum, with a greater number of 
pulses sampled per pixel near the edges of the fast scan axis where the resonant mirror 
was moving the beam more slowly. Compared to the 12.5 ms acquisition time used 
previously, the minimum per-pixel acquisition time for z-cut was 4.8 s (32 averaged 
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frames, each 150 ns), representing a 2600-fold reduction in the measurement time. 
Assuming noise is dominated by Poisson fluctuations in the detected intensity, this 
change corresponds to an anticipated reduction of ~50 in the signal to noise ratio (SNR) 
relative to the previous polarization measurements by NOSE. In that prior work, quartz 
tensor elements could be determined in 12.5 ms with a SNR of ~100. Reducing this value 
by a factor of 50 yields a SNR ratio of approximately 2 in 4.8 s. In practice, the 
measured SNR in a single pixel in an integration time of 4.8 s in the current NOSE 
experiments was typically approximately 5-6, representing approximately a 3-fold 
increase over previous experiments. The most likely explanation for the improvement in 
the SNR in the present work is the higher signal level achievable using fast scanning and 
synchronous digitization for high dynamic range detection rather than photon counting as 
was done in the previous work. 
 Due to the presence of distinct frequencies in the polarization-dependent crystal 
response (e.g., eq. 5.5), it may initially appear that lock-in amplification (LIA) could be 
an attractive alternative to the data acquisition strategy presented here-in. However, the 
harmonics present in equation 5.5 are a function of the polarization state (), not time. As 
equation 5.5 contains further trigonometric functions of a sinusoidal modulation (the 
EOM response, eq. 5.2), direct time-domain LIA of the polarization-dependent response 
would only be valid at very lowly modulation amplitudes such that the harmonics in  
correspond with harmonics in time. Such a change would fundamentally limit the 
polarization states accessible by the EOM and would reduce confidence in the recovered 
values of the Fourier coefficients. From a practical standpoint, the presence of two 
harmonics (, 2) in the polarization-dependent response would require two LIAs per 
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channel across three channels. Maintaining simultaneous calibration between each LIA 
could prove challenging. Finally, uncertainty (bandwidth) in the frequencies recovered 
via LIA is inversely proportional to the data acquisition time – e.g., longer acquisition 
times allow increased confidence in the frequencies recovered via LIA. With integration 
times as short as 150 ns for pixels near the center of a NOSE image (resonant mirror is 
moving the fastest), this corresponds to a broad (~7 MHz) bandwidth in the LIA, which 
would yield increased uncertainties in the recovered polynomial coefficients.   
 Both the naproxen crystals and the two crystalline domains of glucose isomerase 
exhibited large variations in polarization response as a function of crystallographic 
orientation. It is also of note that the net polarization response of naproxen appears to 
differ from the net polarization response of glucose isomerase. For the horizontal SHG 
channel, the naproxen color-map contains largely red, green and purple, whereas the 
glucose isomerase 3D colormap contains crystalline domains of cyan and magenta. This 
difference between samples suggests not only the ability to distinguish between 
differently oriented crystals, but also between different types of crystalline materials. 
This shows promise in the area of API polymorph screening, in cases where full 
orientation mapping and therefore full NOSE analysis may not possible. 
5.5 Conclusions 
  The theoretical framework for SHG ellipsometric microscopy has been presented 
and experimentally verified. By incorporating fast polarization modulation with 
synchronous digitization, it has been shown to provide a substantial reduction in 
acquisition time as compared to previous NOSE techniques without significant loss in 
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precision, allowing for real-time imaging applications. Validation of the technique and 
instrumentation was performed using z-cut quartz with well characterized NLO 
properties as a reference. The experimentally measured Jones tensor elements for z-cut 
quartz fell within error of the theoretical predicted values. The technique was further used 
to explore naproxen and glucose isomerase crystals with the resulting Fourier coefficient 
images showing substantial differences due to crystal orientation. Furthermore, the 
Fourier coefficient maps of naproxen as compared to glucose isomerase crystals 
demonstrate an overall net coefficient difference allowing for not only differentiation of 
crystal orientation but also differentiation of varying crystalline material. Lastly, it was 
demonstrated that by coupling fast polarization modulation synchronously with detection, 
the signal-to-noise of the measurement was sufficient to perform real-time (15 Hz) 
polarization-dependent imaging with as little as 150 ns per pixel integration time and still 
recover statistically significant Fourier coefficients directly connected to the tensors 
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Table 5.1 Jones vectors for a variety of polarization states 
Polarization Jones Vector Illustration 
Linearly Polarized: Vertical ቂ10ቃ  
Linearly Polarized: Horizontal ቂ01ቃ  























Table 5.2 Jones matrices for a variety of common optical elements 
Optical Element Jones Matrix 
Linear Polarizer: Passing Vertical ቂ1 00 0ቃ 
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Figure 5.1 Instrument and timing schematic for a SHG and laser transmittance 
microscope capable of synchronous polarization modulation. The master clock for 
controlling the scanning mirrors and for data acquisition is provided by the laser, 





Figure 5.2 Characterization of the EOM response. Nonlinear fitting of A) horizontally 
polarized transmitted fundamental beam and B) horizontally polarized SHG for z-cut 
quartz rotated to 30 degrees and C) the EOM phase, Δ, as determined from the two 
nonlinear fits. The Δ values for horizontal (H), vertical (V) and left-circularly 
polarizations are also indicated.  The relationship of Δ as a function of time is 





Figure 5.3 Experimental and theoretical normalized Fourier coefficients a and b for the 





Figure 5.4 Summary of polarization-modulation SHG results for naproxen crystals for the 
horizontal PMT. An overall intensity image a) and the same image separated out into its 
10 unique polarization-dependent images b) are shown. The five Fourier coefficient 
images are shown in c), with each coefficient representing a unique color (red, green, 
blue, cyan and magenta for coefficients a, b, c, d and e , respectively). The five 






Figure 5.5 Images of a multidomain glucose isomerase crystal. A 2D laser transmittance 
image of a multidomain glucose isomerase crystal integrated for all 10 polarizations is 
shown in a). Corresponding 3D PCA (principal component 2) and Fourier coefficient 




CHAPTER 6. RAPID DISCRIMINATION OF POLYMORPHIC CRYSTAL FORMS 
BY NONLINEAR OPTICAL STOKES ELLIPSOMETRIC MICROSCOPY 
6.1 Introduction 
Polymorphism, or the presence of multiple crystal forms for a single molecular 
building block, is an important characteristic in the development of therapeutic small 
molecules.1–5 As different polymorphs and crystal forms can exhibit widely varying 
physiochemical properties, including overall formulation stability and drug solubility, 
precise control over crystal form can be critical for reliable drug performance and product 
quality control.1,2,6–8 Additionally, a thorough characterization of generally accessible 
polymorph and cocrystal forms is typically performed prior to establishing intellectual 
property rights on pharmaceutical formulations.9,10 The importance of control over drug 
polymorphic form is perhaps best illustrated by the 1998 recall of Norvir® (oral capsule 
formulation of the HIV protease inhibitor ritonavir) upon discovery of a more 
thermodynamically stable polymorphic form with decreased oral bioavailability.11 As a 
result of these motivations, drug development laboratories spend considerable resources 
on discovering and characterizing the polymorphic forms of an emerging active 
pharmaceutical ingredient (API).12–14 
Trends in the pharmaceutical industry are shifting crystal form analysis to earlier 
stages in the pipelines, targeting analysis of a greater diversity of samples to test with 
ever smaller quantities of available purified product available for testing. High-
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throughput (HT) crystallization procedures intended to empirically map polymorphic 
space for a new drug candidate are playing an increasingly important role in new form 
discovery.8,15–17 While the parallel approach of HT crystallization technology offers an 
overall time savings over traditional serial “batch” approaches, the characterization of all 
crystal forms within multi-well plate crystallizations represents a non-trivial 
measurement task as the available mass of purified materials are reduced. Techniques 
such as Raman spectroscopy,18–21 Fourier transform infrared spectroscopy (FT-IR),22 
powder X-ray diffraction (PXRD),16,18,20,23 differential scanning calorimetry (DSC),18 and 
optical microscopy8,16,20 are currently used to assess the polymorphic form of hits. 
Unfortunately, the time required for characterization by these methods creates a 
bottleneck in the screening process that is ultimately limiting the number of screenable 
conditions. While Raman spectroscopy generally provides shorter characterization times 
(a few sec/measurement)20 relative to other techniques such as PXRD (current state of the 
art requires ~60 sec/ measurement using benchtop systems)16, the overall time required to 
analyze the results of several thousand crystallization experiments routinely exceeds the 
number of trials that can be prepared and run. This disparity is often compounded by the 
need for characterization by more than one analytical method, such that completion of a 
HT study for a new drug candidate can take several weeks to complete.8 The analysis of 
already known crystal forms may occupy a large portion of this characterization time. 
Furthermore, the existing measurement time bottleneck is only likely to pose even greater 
challenges for throughput as the decreased crystal mass in each well in high-throughput 
screens lowers the overall SNR in the measurements. Additionally, preferred orientation 
effects become increasingly important in small samples as the finite set of crystals results 
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in a stochastic set of discrete crystal orientations.24,25 Preferred orientation can 
significantly complicate automated analysis of the observed spectra;8 rotation is a 
nonlinear operation, such that the measured Raman spectra and XRD patterns produced 
from non-representative sampling generally cannot be expressed as simple linear 
combinations of pure components. As a result, linear decomposition methods of the 
spectra such as principal component analysis and linear discriminant analysis are often 
intractable. A need has thus emerged for additional complementary characterization 
approaches that can decrease characterization times from trace quantities of material in 
HT new crystal form discovery. 
Second harmonic generation (SHG) has been suggested as an alternative method 
for crystal polymorph determination. In studies by Rades et al., differences in the angle-
dependent SHG scattering were linked to changes in crystal form.26 However, the 
discriminatory capability of conventional powder analysis by SHG is limited primarily to 
differences in the overall intensity produced by a powder,27,28 which provides fairly small 
discriminatory capability, requires sufficiently large samples to provide representative 
sampling as in XRD and Raman, and is highly dependent on crystal size effects.29,30  
Nonlinear optical Stokes ellipsometry (NOSE), combining rapid (8 MHz) polarization 
modulation of the incident beam and polarized detection of the second harmonic, has 
recently been shown as a measurement technique sensitive to both small molecule crystal 
form and orientation ,31–33 increasing the information content of previous SHG 
microscopy studies.34 This technique has the potential to alleviate measurement 
bottlenecks found in HT crystallization studies through the Boolean discrimination and 
subsequent removal of already-discovered crystal forms from more time-consuming 
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analysis pipelines. Because NOSE is based on polarization-dependent measurements, it 
has self-referencing measurement advantages over SHG measurements based on intensity 
alone. Additionally, recovery of individual crystal orientations by NOSE microscopy 
allows tensor analysis in the local-frame of the crystal, such that crystal form 
determination can potentially be achieved even in samples containing only a handful of 
microcrystals. Polymorphic analysis by NOSE has the additional potential advantages of 
being fast (approaching video-rate) and non-destructive. Combining NOSE with 
birefringence and traditional optical microscopy all acquired simultaneously on one 
platform also opens up the possibility for the combination of multimodal analyses. 
Here, we assess the potential merits of NOSE for rapid crystal form 
discrimination using two polymorphic forms of the small molecule D-mannitol. D-
mannitol was selected as a model system for several reasons. First, several polymorphic 
forms are readily accessible via simple room-temperature recrystallizations.35 
Additionally, D-mannitol is an exceedingly common small-molecule excipient used in 
pharmaceutical formulations. Disentanglement of crystal structure and orientation allows 
the recovery of local (crystal) frame nonlinear optical tensor elements describing the 
polarization-dependent SHG efficiency for a given crystal. These unique tensor elements 
serve as the experimental observable for discrimination on a per-crystal basis. Polymorph 
discrimination based on NOSE is shown for orthorhombic (P212121) and monoclinic 
(P21) structures of D-mannitol. The potential for discrimination was assessed from 
measurements of only ~1 g of material, consistent with compatibility with small volume 
HT crystallization studies.  
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6.2 Materials and Methods 
6.2.1 Experimental 
D-Mannitol was purchased from Sigma-Aldrich. Orthorhombic and monoclinic 
forms of D-mannitol were crystallized from different solvents according to previously 
published protocols.36,37 The orthorhombic form was recrystallized from 70/30 
ethanol/water, and the monoclinic form was obtained via an anti-solvent crystallization 
from 50/50 water/acetone. Powder X-ray diffraction (PXRD) patterns were obtained on a 
Rigaku SmartLab® X-ray diffractometer, using a wavelength of 1.554 angstroms and a 
scan speed of 0.6 2/min. Acquired PXRD patterns were compared to those predicted by 
Mercury® (Cambridge Structural Database, CSD).38 Entry IDs of CSD entries were 
DMANTL8 (orthorhombic) and DMANTL14 (monoclinic). 
 NOSE images were required on a custom microscope capable of 8 MHz 
polarization modulation described in detail in several previous publications.31,33 In brief, 
an 800 nm, 80 MHz, 100 fs Ti:sapphire laser (SpectraPhysics) at an average incident 
power of 200 mW was used as the light source, and focused onto the sample using a 10x, 
0.3 NA objective (Nikon). The laser serves as the master clock for the beam-scanning and 
data acquisition electronics. The microscope utilizes a resonant mirror (~8 KHz, EOPC)/ 
galvanometer mirror (CambridgeTech) for beam scanning and PCI express digital 
oscilloscope cards (AlazarTech) as the ADC. SHG is separated from the fundamental via 
a series of dichroic/ band-pass optical filters, and photomultiplier tubes (PMT) 
(Hamamatsu) are used as detectors. An electro-optic modulator (EOM) is used for 
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polarization modulation at 8 MHz (laser serves as master clock), and is oriented at +45 
from its fast axis. Glan-Taylor polarizers (GTs) were placed before the two PMTs 
(transmission direction), with a quarter wave plate (QWP) oriented at +22.5 placed after 
the sample, prior to the polarizer. A GT was also placed before a photodiode 
(transmission direction) to allow polarized detection of the laser fundamental.  
 
6.2.2 Computational 
Following image acquisition, OrientationJ (NIH ImageJ) and custom Matlab 
software were used for analysis. ImageJ was used to threshold the SHG images, allowing 
particle (crystal) analysis. The SHG intensity for each input polarization was averaged 
across each individual crystal. The ten polarization-dependent responses are then 
contracted down to a set of five Fourier coefficients via linear least-squares fitting 
(Matlab) as described previously.31 These Fourier coefficients are a function of both 
sample orientation (described by Euler angles , , and ) and intrinsic polarization-
dependent nonlinear optical susceptibility. A custom iterative, nonlinear least-squares 
fitting algorithm was developed for the analysis of NOSE images. This algorithm has 
been described in detail in related publications,32,33 and recovers two unknown orientation 
angles (, ), the per-crystal SHG intensity, and the values of the local-frame nonlinear 
optical susceptibility tensor elements.  For each crystal in the image (particles identified 
via ImageJ), the in-plane azimuthal rotation angle () was measured with the OrientationJ 
plug-in (NIH ImageJ).  
 Following conversion of the Fourier coefficients to an alternative set of 
polynomial coefficients, the coefficients and in-plane orientation angles for each crystal 
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were used as inputs into the iterative fitting algorithm. In the first step, a user-defined set 
of local-frame nonlinear optical susceptibility tensor elements and the in-plane 
orientation angle (recovered from OrientationJ) were assumed, and a nonlinear least-
squares fit of the polynomial coefficients to recover the remaining two orientation angles 
and the per-crystal SHG intensity was performed. Following completion of the fit, the 
obtained values for , , and the per-crystal  SHG intensity were assumed explicitly, and 
an additional nonlinear least-squares fit to recover local-frame tensor element values 
(constrained fit) was then performed. This entire process was iterated until the system 
converged. As described in the related publications,32,33 the algorithm has been validated 
on both theoretical data of multiple symmetries and thinly-sectioned porcine/ mouse 
collagenous tissue samples. Due to sensitivity of the recovered orientation angles on 
initial parameter guess values (i.e., equivalent solutions are found), the iterative algorithm 
was subjected to 100 independent runs with randomized guess values for  and . The 
mode of the recovered values for the local-frame tensor elements and orientation angles 
for each crystal was used for subsequent analysis. 
The symmetry properties of the D-mannitol structures studied herein yield 3 and 
13 unique non-zero tensor elements for the orthorhombic (P212121) and monoclinic (P21) 
structures, respectively. Together with 2 orientation angles this yields 5 and 15 recovered 
variables, respectively, for the measurement. As the number of recovered parameters for 
the P21 structure exceeds the number of observables, direct recovery of all unique non-
zero tensor elements for the monoclinic form is not anticipated to be accurate (high 
covariance) and was thus not attempted. However, the goal of this study is simply 
Boolean discrimination of orthorhombic structures for the purpose of identifying a 
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common crystal form. Accordingly, NOSE measurements of both the monoclinic and 
orthorhombic crystal structures were fit to the equations describing the orthorhombic 
response to recover 3 unique local-frame tensor elements (along with per-crystal SHG 
intensities and two orientation angles) for each crystal structure. Following 2-class linear 
discriminant analysis (LDA) for optimal dimension reduction, statistical tests (F test and t 
test) were then used to provide a quantitative means of making the Boolean structure 
discrimination through comparison of the probability density functions (pdfs) giving rise 
to the responses for the “known” form  (orthorhombic) and the “unknown” form 
(monoclinic). 
6.3 Results and Discussion 
D-Mannitol was crystallized into two polymorphic forms via recrystallization 
from common solvents. These two forms adopt orthorhombic (P212121) and monoclinic 
(P21) symmetries. Confirmation of the two crystal structures was performed via PXRD. 
Figure 1 contains the observed diffraction data together with the predicted patterns from 
the Cambridge Structural Database (CSD)38 for both the orthorhombic (CSD ID 
DMANTL8) and monoclinic (CSD ID DMANTL14) crystal forms, based on the reported 
lattice constants and nuclear electron densities. Although there are some disparities in the 
relative peak heights, excellent agreement between most 2 diffraction angles is 
generally observed.  
NOSE colormaps of orthorhombic (left column) and monoclinic (right column) 
forms of D-mannitol are shown in Figure 2 for both the horizontally polarized PMT (H 
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PMT) and the vertically polarized PMT (V PMT). NOSE colormaps are created through 
linear fitting of the n-polarized SHG intensities to a set of five Fourier coefficients as 
described previously and shown in Equation 1.  
 
2 cos(2 ) cos( ) sin( ) sin(2 )n n n n n nI a b c d e
             6.1 
 
The polarization state of the incident light emerging from the EOM is dependent on the 
phase shift  in Equation 1, with the values of a-e Fourier coefficients shown as merged 
red, green, blue, cyan, magenta (RGBCM)  images in Figure 2. The relative magnitude of 
each coefficient (a,b,c,d,e) provides the color weighting (RGBCM, respectively) within 
each pixel of the image. These images thus contain all polarization-dependent NLO 
information recovered from the measurement. As described previously,31 further analyses 
are performed following linear conversion of the above Fourier coefficients to an 
alternative set of polynomial coefficients. While the images shown in Figure 2 were 
obtained through linear fitting on a per-pixel basis for ease in visualization, the 
subsequent data analysis presented herein involved linear fitting after averaging the 
polarization-dependent SHG response across each individual crystal. The amplitudes of 
the Fourier coefficients depend upon both the inherent polarization-dependent SHG 
activity and the orientation of each crystal within the field of view. The inherent 
polarization-dependent SHG activity for a crystal is described by a rank 3 tensor, where 
each scalar entry describes the efficiency and relative phase of frequency doubling given 
defined polarizations for both the incident and exiting fields. SHG expressed in the local 
Cartesian frame for the crystal can yield as many as 18 unique non-zero tensor elements 
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for a material. However, many of these tensor elements are equal or zero-valued by 
symmetry, with higher symmetry materials containing more zero-valued entries.  
 The first method assessed for discrimination was based on statistical analysis of 
the directly recovered Fourier coefficients. Two-class linear discriminant analysis (LDA) 
was performed on these coefficients. These results are summarized in Figure 3. 
Following projection onto the Fischer discriminant, histograms of the pooled response 
from crystals of each structure were constructed to visually compare separation of the 
probability density functions (pdfs). The data were also compared via a conventional F 
test and t test to quantitatively assess statistical independence of the variances and means 
(respectively) of the two experimental distributions. The t test is only performed if the 
distributions first pass the F test, indicating that the variances in the compared data are 
not statistically distinguishable with 99.99% confidence. Figure 3 shows a histogram of 
the raw coefficients following LDA for the orthorhombic (blue) and monoclinic (red) 
structures. Calculated values for the F and t tests are shown in Table 1 with green 
indicating a pass and red indicating a failure of the test. 
Two different contributions to the separation were considered; changes in the 
polarization-dependence and differences in the orientation-corrected, per-crystal SHG 
intensities. The raw coefficients giving rise to the histograms shown in Figure 3 vary in 
response to changes in all of these quantities. To aid in understanding the role of the 
orientation-corrected, per-crystal SHG intensities in driving the separation of these 
distributions, the raw polynomial coefficients in Figure 3 were intensity-normalized 
through division by the per-crystal intensity values found via the iterative, non-linear 
least squares fitting algorithm. Figure 4a shows histograms of the projected coefficients 
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after intensity-normalization. Additionally, histograms of these orientation-corrected 
intensity values are shown directly in Figure 4b. Calculated F and t values are shown in 
Table 1.  
All statistical tests presented herein assume a 99.99% confidence interval. In 
brief, the recovered distributions following LDA of the raw polynomial coefficients pass 
the F test but fail the t test, indicating that the pdfs giving rise to these distributions have 
statistically independent means within the 99.99% confidence interval. The intensity-
normalized polynomial coefficients pass both the F and t tests (i.e., no statistically 
significant discrimination at the given confidence interval can be achieved in either the 
variance or the mean projected along the LDA axis). From inspection of the color-maps 
(Figure 2), it is clear that in-plane orientation of the crystals contributes significantly to 
the diversity of polarization-dependent responses observed in the laboratory frame. 
To disentangle the effects of laboratory-frame crystal orientation from those of 
inherent local-frame polarization dependence of the crystals, the above analyses were 
repeated for the local-frame tensor elements obtained via the iterative, non-linear least 
squares fitting algorithm. These results are summarized in Figures 5 and 6. Figure 5 
shows histograms of the raw local-frame tensor elements obtained for each crystal 
structure, with the calculated F value shown in Table 1. The orientation-corrected 
intensities obtained via nonlinear least-squares analysis (Figure 4b) can also be included 
when analyzing the distributions of the local-frame tensor elements. For visualization 
purposes, a scatter plot showing the local-frame tensor elements for each crystal form 
after multiplication by the per-crystal intensities recovered via the iterative nonlinear 
least-squares analysis is given in Figure 6a. The larger variance of the monoclinic 
103 
 
structures relative to the orthorhombic structures is readily observed. Figure 6b shows a 
histogram of the data in 6a following LDA. The calculated F value for the distributions 
shown in Figure 6b is also included in Table 1. Both the local-frame tensor elements and 
the intensity-corrected local-frame tensor elements fail the F test, as summarized in Table 
1. 
Collectively, these tests yield information on the primary mechanisms responsible 
for discrimination in NOSE microscopy measurements of crystal forms. The raw 
polynomial coefficients, which contain both intensity and polarization information, pass 
the F test but fail the t test following LDA. However, these data pass both the F and the t 
tests and are statistically indistinguishable after removing the intensity information from 
each set of polynomial coefficients on a per-crystal basis. When considering only 
orientation-corrected, per-crystal SHG intensities and no polarization-dependent 
information, the results from the two crystal forms fail the F test, indicating statistically 
significant discrimination. These combined results are consistent with the disparity in 
orientation-corrected, per-crystal SHG intensities between the two samples serving as the 
primary discriminatory property when laboratory-frame polynomial coefficients are used 
for the discrimination.  
These results are also consistent with diverse crystal orientations being the next 
most dominant mechanism dictating the value of the polynomial coefficients, suggesting 
the potential for improved discrimination when using orientation-corrected local-frame 
tensor elements instead of laboratory-frame polynomial coefficients. Consistent with this 
expectation, the calculated F values following LDA of the derived local-frame tensor 
elements are significantly higher (effectively infinite discrimination) than those found 
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following LDA of the laboratory-frame polynomial coefficients. These results are 
consistent with increased separation observed between the two structures once the 
orientation-dependence of the nonlinear optical crystal response is removed. Fcalc for the 
intensity-corrected local-frame tensor elements is greater than Fcalc for the raw local-
frame tensor elements. This increase indicates that the discriminatory capability is further 
improved when combining both the orientation-corrected per-crystal SHG intensities and 
the local-frame polarization-dependence. While orientation-corrected per-crystal SHG 
intensity information alone may enable structure discrimination under the experimental 
conditions in the present work, the confidence in that discrimination further improves 
when also considering polarization-dependent effects. Considering hypothetical NOSE 
measurements with lower SNR than in the present study, it is possible that discrimination 
could be enabled when considering these combined observables, but not feasible when 
considering only the orientation-corrected per-crystal SHG activities. It is also worth 
noting that the scalar intensities found via the nonlinear fitting algorithm in the present 
study differ from the scalar intensity quantities in previous works. Scalar intensities 
found through single-point measurements on bulk powdered samples26–28 are sensitive 
not only to crystal polymorphic form, but also to the presence or absence of phase 
matching, the packing density, orientation distribution, and particle size distribution of 
the sample. Several of these sources of ambiguity have been addressed in more recent 
studies based on SHG microscopy of powders.39 In contrast, the single-crystal, 
orientation-corrected intensities presented here-in have largely removed the dependence 
on packing density, orientation, and phase-matching, further isolating the effects from 
polymorphism on the overall SHG intensity.  
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While the recovery of local-frame tensor elements was demonstrated for the 
P212121 and P21 crystal classes in this work, this strategy can be generalized to other 
crystal classes. Formally, the process of SHG is symmetry-allowed in any crystal lattice 
without an inversion center (noncentrosymmetric). Thus, discrimination of crystal 
structures by NOSE should in theory be possible under the simple constraint that all 
crystal classes involved are noncentrosymmetric. The general ability of NOSE for 
discriminating specific crystal classes is highly dependent on the differences in molecular 
packing and orientation relative to the crystallographic coordinates, such that general 
conclusions should be made cautiously. Fortunately, relatively simple molecular-level 
calculations can provide reasonable estimates regarding the discriminatory capability of 
NOSE. Previous work has demonstrated good correspondence between ab initio 
predictions and experimental orientationally averaged SHG activities.40 It is reasonable to 
expect similar reliability for prediction of the polarization-dependent differences between 
unique crystal forms. The current experimental architecture yields limits on the number 
of local-frame tensor elements recoverable via the iterative nonlinear least-squares 
analysis. However, the addition of a quarter wave plate to the beam path (pre-sample) and 
repetition of the data acquisition at multiple wave-plate rotations could provide additional 
independent measurements and enable the recovery of a higher number of local-frame 
tensor elements.  
The use of NOSE for polymorph discrimination offers several other advantages 
consistent with practical considerations in performing HT crystallization studies for 
crystal form discovery. While the polymorphs were synthesized at a relative large (~g) 
scale for ease of preparation, the actual microcrystalline mass used for discrimination is 
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estimated to be approximately 1 g. This mass is consistent with per-well mass values 
typically encountered in small-volume HT crystallization studies. Additionally, NOSE 
imaging can be performed rapidly. Each FOV in the present study took approximately 7 
seconds to acquire, although the observed SNR in the SHG images (~300) and high 
confidence in the subsequent statistical tests suggests this acquisition time could be 
significantly reduced. In any measurement, the limits of quantitation are always greater 
than the limits of detection, including the present case. One of the key enabling 
advantages of the NOSE measurement approach is dramatic reduction in the 1/f noise 
produced in analogous wave plate-based measurements, such that significantly greater 
confidence can be assigned with shorter measurement times.   NOSE imaging at video 
rates has been demonstrated previously.31 Additionally, while the two polymorphic forms 
were kept physically separated to ease validation (e.g., PXRD) in this proof-of-concept 
study, the analysis presented here (performed on a per-crystal basis) is readily applicable 
to mixtures of polymorphic forms. Within the assumption that the individual crystals 
within a multi-structure mixture could be prepared in a manner that minimizes physical 
crystal overlap, the methodologies presented in this manuscript should directly enable 
structure discrimination. Finally, it is worth emphasizing that the discrimination 
demonstrated in this study is based solely on the SHG measurements alone. Additional 
considerations such as crystal habit (e.g., needle, plate, etc.) could provide additional 
complementary indicators for polymorphism discrimination based on image analysis. 
Given that the SHG is expected to be largely independent of crystal habit, the two 
methods should be largely orthogonal. Although not the primary subject of the present 
study, additional discrimination capabilities are possible by combining the NOSE 
107 
 
measurements with polarization-dependent laser transmittance microscopy, which is 
performed concurrently with NOSE imaging. Bright field imaging is commonly used to 
identify crystal formation (hits) and crystal structures/ habits in HT studies; the laser 
transmittance images obtained in NOSE retain this imaging modality. Furthermore, the 
polarized detection present on this channel allows recovery of observables describing 
sample birefringence, another modality commonly used in the assessment of crystal 
forms in HT studies. However, the polarization-dependent changes arising from 
birefringence were generally relatively subtle compared to analysis by NOSE, and highly 
dependent on the thickness of the crystals.  
These collective results suggest the viability of NOSE for rapid polymorph 
discrimination for fast pre-screening. This first study was limited to the discrimination of 
two polymorphic forms. In principle, extension to systems exhibiting many accessible 
polymorphic forms simply represents expansion to n-class LDA. In practice, the high 
degree of discrimination achieved from recovery of the local-frame tensor elements and 
intensities suggests optimism in generalization of this approach to higher numbers of 
crystal forms.   
The recovery of crystal orientation angles also has the potential to benefit analysis 
of HT crystallizations by PXRD and Raman. In the event that an outlier is detected based 
on NOSE microscopy as demonstrated herein, a natural next step would be to confirm or 
refute by an orthogonal method such as PXRD or Raman. The limited number of crystals 
typically found in modern solid form screens can complicate analysis by both methods 
due to significant preferred orientation effects in the observed scattering patterns.24,25 
Accounting for these effects through increased data acquisition (e.g., repeating the 
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measurement at a variety of sample orientations) requires significant additional analysis 
times. The crystal orientation information recovered through NOSE could potentially be 
fed into these pipelines and used to correct for preferred orientation effects, helping to 
alleviate these additional bottlenecks in crystal characterization. In this manner, NOSE 
measurements may serve double-duty, first for identification of outliers and next to aid in 
subsequent orthogonal analyses.  
6.4 Conclusions 
NOSE microscopy has been shown to allow highly confident (>99.99%) 
discrimination of orthorhombic and monoclinic crystal forms of D-Mannitol in a few 
seconds of total measurement time. Rapid (8 MHz) polarization modulation allows the 
recovery of a set of polynomial coefficients for each sample at <7 seconds per FOV with 
a SNR of ~300. These coefficients enabled discrimination directly, following two-class 
LDA for dimension reduction. However, substantial improvements in discrimination 
were achieved by correcting the polarization-dependent measurements for local crystal 
orientation. Transformation of the polarization-dependent response to the local-frame 
allowed direct recovery of the tensor elements for the P212121 crystal form and confident 
detection of the P21 crystals that were not well described by those recovered local-frame 
tensor elements. Furthermore, the complete analysis was performed using only ~1 g of 
crystalline material. These collective results have the potential to help address bottlenecks 
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Table 6.1 Summary of statistical tests. Green shading indicates a pass, red shading 











System Fcalc tcalc 
Raw Polynomial Coefficients 1.35 10.8 
Intensity-Normalized Coefficients 1.18 ~0 
Per-crystal Intensities 2.61* - 
Raw Local-Frame Tensor Elements 14.4 - 




Figure 6.1 Summary of PXRD results. Experimental (solid trace) and predicted (dotted 
trace) PXRD patterns for orthorhombic (blue, bottom) and monoclinic (red, top) crystal 
structures of D-mannitol. Patterns are artificially offset vertically for clarity. Predicted 
patterns were obtained from the Cambridge Structural Database (CSD), entry IDs 
DMANTL8 and DMANTL14, respectively. General agreement between the experimental 





Figure 6.2 NOSE colormaps for two crystal structures of D-mannitol. Values of a-e from 
equation 1 are shown as a merged RGBCM image for each of two photo detectors 
(horizontally and vertically polarized PMTs). The values of a-e collectively describe all 
polarization-dependent nonlinear optical properties of the sample, including the 
combined effects of both inherent polarization-dependent SHG activity and crystal 





Figure 6.3 Histograms following two-class linear discriminant analysis of the raw 
polynomial coefficients for orthorhombic (blue) and monoclinic (red) forms of D-





Figure 6.4 Histograms for the intensity-normalized polynomial coefficients following 
LDA (A) and for the raw intensities obtained from the iterative nonlinear least-squares 
fitting algorithm (B). The distributions in (A) pass both the F test and the t test, while the 
distributions in (B) fail the F test. These results are consistent with the orientation-
corrected, per-crystal SHG intensities being the primary mechanism enabling 





Figure 6.5 Histograms of the raw local-frame tensor elements following LDA for 
orthorhombic (blue) and monoclinic (red) forms of D-Mannitol. The recovered 





Figure 6.6 Raw data and histograms for the intensity-corrected local-frame tensor 
elements. Scatter plot (A) and histograms following LDA (B) for orthorhombic (blue) 
and monoclinic (red) forms of D-Mannitol. The scatter plot in (A) allows direct 
visualization of the increased variance in the intensity-corrected local-frame tenor 
elements observed for the monoclinic structures relative to orthorhombic structures. The 




CHAPTER 7. DIGITAL DECONVOLUTION FILTER DERIVED FROM LINEAR 
DISCRIMINANT ANALYSIS AND APPLICATION FOR MULTIPHOTON 
FLUORESCENCE MICROSCOPY 
7.1 Introduction 
 Accurate quantitation of optical signals in NLO microscopies is necessary to 
preserve the signal to noise (SNR) advantages of the measurement approaches discussed 
in previous chapters. For measurements based on photon counting, saturation of the 
detector (e.g., a photomultiplier tube) can severely limit the linear dynamic range of the 
measurement. This problem is of particular interest in SHG/ TPE-UVF images of APIs, 
due to the 7-decade range of intrinsic API crystal brightness for both NLO processes. 
Arguably the most common problem limiting the LDR of photon-counting measurements 
is known as “pulse pile-up,” in which high photon flux rates cause overlapping response 
peaks in the time-dependent voltage trace emerging from the photo-detector. In 
traditional photon-counting methods, a count is recorded when the voltage vs. time trace 
passes a pre-defined threshold on the rise. If two photons are either 1) time coincident or 
2) closely spaced in time such that the voltage does not drop below the threshold before a 
second event occurs, bias from undercounting arises. Accordingly, the maximum count 
rate plateaus as photon flux increases. 
 A number of previous strategies have sought to increase the LDR of photon-
counting measurements. One common approach is to operate multiple detectors in 
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parallel, where the total photon flux is intentionally distributed among multiple channels, 
decreasing the LDR required on a single channel.1–4 In addition to increasing costs, such 
a strategy necessarily diminishes the SNR of the measurement. The use of multiple 
detectors also increases the number of dark counts in the measurement, potentially 
increasing limits of detection. Another method relies on imposing a “dead time” 
following a counting event, whereby the signal is intentionally neglected for a short 
period time following a count to allow the voltage to return below the threshold before 
another count can be recorded.5 Known as paralysis, this technique can be effective at 
low count rates, but may increase data acquisition times and has a limited LDR.  
 Techniques to increase the LDR of counting measurements based on curve-fitting 
have also been demonstrated.2,6–9 Such strategies often rely on prior knowledge of the 
impulse response function, where the peak temporal location and height can be recovered 
through curve fitting of the raw voltage vs. time data.  While effective for the recovery of 
accurate count rates,10–13 such strategies are generally time-consuming in their 
implementation, particularly at high (> mega counts per second, Mcps) count rates as are 
often encountered in NLO microscopy (a curve fit is required at every data point).  
 New strategies based on deconvolution of the instrument response function (IRF) 
from the raw voltage vs. time data could have the potential to increase the LDR of 
photon-counting measurements. If a temporal impulse could be recovered from the raw 
data, pulse pile-up may be largely avoided, as voltage transient life time is dramatically 
reduced.14 For raw data emerging from the analog to digital converter (ADC), digital 
filtering is an attractive option for deconvolution due to its speed and relative simplicity. 
Weiner-type digital filters, intended to deconvolve the IRF from the raw data, have been 
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widely used for this purpose. While successful when the IRF is known a priori, Wiener-
type filters do not perform as well when the IRF is an unknown form or when 
measurement noise is not normally distributed. 
 In the present study, a novel digital filter developed from linear discriminant 
analysis (LDA) is presented. The filter is generated by finding the optimal axis of 
separation for time-coincident (class 1) and time non-coincident (class 2) voltage 
transients. Following training for generation of the filter, the performance of the filter 
was tested via simulations at a variety of photon flux rates and noise levels. The 
algorithm was also used to correct for a complex IRF in two-photon UV fluorescence 
images containing significant ringing in the voltage transients. Complementary 
simulations with the same ringing IRF showed the ability of the algorithm to extend the 
linear dynamic range of the measurement by over an order of magnitude relative to other 
approaches.  
7.2 Theoretical Foundation 
Digital filtering is a common technique with a variety of applications in signal 
processing. Here, digital filtering is performed in the time domain via convolution of the 
filter function with the time-domain raw data. The process of digital filtering for discrete 
signals is shown in Figure 7.1. A model voltage transient representing an exponentially 
decaying IRF is shown in blue, and the digital filter is shown in red.  Filtering through 
convolution of the data and the filter is performed by a sliding dot product, in which the 
scalar output replaces the data point coincident with the center (origin) of the filter. The 
filtered output is shown in green in Figure 7.1 (offset horizontally for clarity).  
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The digital filter used here-in seeks the recovery of a sharp temporal impulse 
through deconvolution of the IRF, and is generated via 2-class LDA. LDA is a supervised 
multivariate method of data analysis for the separation of data into distinct groups. The 
two classes used for training the digital filter are time coincident and non-coincident 
voltage transients, in which the peaks either overlap temporally with the center (origin) of 
the filter or are randomly shifted in time, respectively. Voltage transients for each class 
are shown in Figure 7.2, with coincident transients shown in red and non-coincident 
transients shown in blue. The digital filter and the projection of the two classes in filter 
space are also shown. Defining the two classes for LDA in this way creates a filter 
(projection axis) that maximizes the resolution between voltage transients that are 
centered at the filter origin (class 1) and any temporally neighboring transient (class 2). 
Mathematically, it is the scalar value of the Fisher discriminant15 that is maximized 
according to the following equation: 








   7.1 
Where w  is the direction within voltage transient space the provides maximum 
separation between the two classes. Here, c and n correspond to the projected (scalar) 
values of the average voltage transients from each class, and sc and sn are the projected 
variances for each class. The axis w  is found through solving the eigenvector-eigenvalue 
equation shown below. 
 1W BS S w Jw
     7.2 
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Where the matrices WS  and BS  represent the within and between class variance 
(respectively), and are given by the equations below 
 ( ) ( )TB c n c nS            7.3 
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With an analogous expression for 
nW
S (not shown). ix
  indicates the ith vector from the 
relevant class ( cN  total vectors in the coincident class, “c”), and  c  is the average vector 















   7.5 
When the origin of the filter (typically the center) is time-coincident with the onset of the 
transient, the scalar output of the filter is given by the dot product of the filter with the 
transient. Analogously, application of the filter function in a non-coincident position will 
correspond to a projection of the non-coincident class. Consequently, convolution of the 
time-trace by the digital filter F generated by LDA maximizes the contrast between 
coincident and non-coincident events to optimally recover deconvolved -function 
(impulse) single-pixel maxima at the location of the transient onsets.  
 Following application of the LDA-based digital filter, a conventional high pass 
(HP) filter is used to remove rolling background features introduced by the LDA-based 
filter. In practice, these two filters may be combined (convolved) to enable single step 
LDA and HP filtering. Subsequently, traditional threshold-based counting is performed, 
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in which a count is registered with the data trace crosses and arbitrary threshold on the 
rise.  
7.3 Materials and Methods 
 Simulations with known ground-truth results were performed to assess the 
performance of LDA-derived digital filtering relative to both conventional photon 
counting and signal averaging.  To produce the training sets, each photon generated a 
random peak height corresponding to a lognormal distribution in gain in the PMT. A 
mean µL of 7 mV and standard deviation L of 4 mV describing the lognormal 
distribution were selected based on measured characteristics for PMTs similar to those 
used in the present study. The temporal impulse response was also approximated by a 
lognormal function. For the coincident training set, the initial onset of the pulse was 
assumed to be at time zero in the center of the filter. The non-coincident training set was 
generated by offsetting the initial onset by normally distributed random shifts .  Each 
trial also included addition of random 1/f noise, generated by Fourier transformation of 
normally distributed time-trace, multiplication by ඥ1 ሺ݂ ൅ ܾሻ⁄ , in which f is the 
frequency and b = 0.005 is a constant describing the time-scale for 1/f fluctuations, 
followed by inverse Fourier transformation to recover a time-trace. Qualitatively similar 
results were observed with normally distributed random noise. 
 In the simulations of the experimental data acquisition, each time-point contained 
a Poisson-distributed random number of photons, where  was the mean of the Poisson 
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distribution (typically less than 1). The time-traces also included 1/f noise calculated 
identically as the simulated data used to generate the training sets.  
 The probability of two or more photons arriving within a single time-step 
becomes non-negligible as the mean of the Poisson distribution approaches unity, which 
can introduce additional bias not accounted for directly by deconvolution alone. The 
LDA-filtering approach is designed to maximize the separation between transients 
produced at separations of more than one time-step of the digitizer, and will therefore not 
be able to correct for the recording of a single count from two or more simultaneous 
photons. Fortunately, this source of bias can be corrected by connecting the measured 
counts (distributed according to a binomial distribution, with only two possible 
outcomes) to the underlying number of photons described by a Poisson distribution. 
Using algorithms developed previously,10,11 the mean  and standard deviation  of the 
Poisson distribution in a given t time window are given below, where p is the mean 
probability for successful counting and N is the number of measured time-points used to 
assess the mean.  







     7.7 
 For a sufficiently large number of measurements, the experimental mean of p 
provides a reasonable estimate for the true mean of p, from which the mean and standard 
deviation of the underlying Poisson distribution can be determined through Equations 5 
and 6.  
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Two –photon excited ultraviolet fluorescence (TPE-UVF) images of pure L-
tryptophan crystals (Sigma- Aldrich) were acquired using a custom microscope. Briefly, 
a Fianium Inc,  ultrafast fiber laser (1060 nm, 150fs, 80MHz) output was doubled to 
generate 530 nm,  which served as the incident light source for TPE-UVF excitation. The 
incident beam was scanned along the fast axis using a resonant vibrating mirror (~4 kHz) 
and along the slow axis using a galvanometer mirror. The scanned beam was directed 
through an inverted Nikon microscope (TE2000) through telocentric lens pairs and 
dichroic mirrors and focused onto the sample using a 10X objective (Nikon), as described 
previously TPE-UVF signal was split into its horizontal and vertical components using a 
Glan-Taylor polarizer, both of which were detected on two separate photomultiplier tubes 
(PMTs) in the reflected direction. TPE-UVF signal was passed through a filter stack (440 
nm high pass and 532 nm high pass filters, Semrock) to reject the fundamental 530 nm 
light and pass two-photon tryptophan emission (~350 nm).  The voltage transients from 
the photomultiplier tubes were flash digitized using oscilloscope cards from AlazarTech 
(ATS 9462) at 80MHz, with the laser providing the master clock to the digitizer cards. To 
artificially produce a noisy ringing transient, the oscilloscope cards were set to an internal 
impedance of 1 MΩ and the PMT with a nominal impedance of 50 Ω was connected to 
the oscilloscope cards with a 20m long cable and a 400 Ω resistor in parallel at the 




7.4 Results and Discussion 
The LDA-based digital filter was trained using two sets (classes) of 6000 voltage 
transients each (time coincident and non-coincident). Example voltage transients for each 
class, the derived filter, and the projection of each training set in filter space are shown in 
Figure 7.2. Simulations of the performance of the filter were performed across a variety 
of photon flux levels, expressed as the mean of the Poisson distribution (). For these 
simulated data, the ground truth temporal locations of photon arrival times are known a 
priori, allowing assessment of the performance of the filter through identification of false 
positives/ false negatives. Figure 7.3 shows the performance of the filter across three 
values of . The distinct photon events are easily discernable by eye in each data trace, 
although simple threshold-based counting is likely to miss photon events in the middle 
(=0.05) and bottom (=0.10) data traces due to pulse pile up. The data trace following 
LDA + HP filtering is shown in blue, and the counting threshold is shown in green. 
Photon counting of the filtered data correctly recovered all photons with zero false 
positives for the each data trace shown (pink bars).  
The effects of threshold position can be assessed via a receiver operating 
characteristic (ROC) curve, in which the true positive rate is plotted against the false 
positive rate at for a variety of threshold settings, as shown in Figure 7.4. Curves at 
multiple values of  are shown. An optimal measurement (maximized true positives and 
minimized false positives) would appear as a data point at the upper left of the plot. The 
shifting of the curve away from the upper left corner as  increases is expected, as pulse 
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pile-up becomes more likely. However, the algorithm still performs well (~80% true 
positive rate) even at incredibly high ( = 0.4) photon fluxes.  
Following these simulations, the performance of the filter was also assessed for 
experimental data with a complex IRF by inducing ringing effects in the voltage 
transient. This was accomplished through the inclusion of a 400  resistor in parallel 
with the 1 M internal resistance of the digital oscilloscope card. By using a long (20 m) 
transmission cable, a time delay between each reflection is introduced, yielding a ~700 ns 
decay time in the IRF ring-down. An example of the ringing IRF is shown in Figure 7.5a. 
Figure 7.5b shows the digital filter derived for this IRF after LDA. Raw data containing 
the ringing IRF is shown in Figure 7.5c (red trace), along with data after LDA-based 
filtering alone (green trace) and LDA + HP filtering (blue trace). The presence of two 
distinct photon events is clear through visual inspection of the red trace (given the 
waveform of an individual IRF shown in 7.5a.) The LDA + HP filtered data recovers 
impulses at each of these time points, and has eliminated the ringing shown in the red 
trace.  
Two-photon ultraviolet fluorescence (TPE-UVF) images of tryptophan were 
acquired under both normal conditions (50  termination) and with the ringing waveform 
discussed above. These measurements were performed simultaneously through the use of 
a polarizing beam-splitting cube after the sample, with two PMTs operating in parallel. 
Figure 7.6a shows the TPE-UVF image of tryptophan from the impedance-matched 
channel, while Figure 7.6b is the raw image obtained from the PMT with the ringing IRF. 
Insets show raw time-domain data for each configuration. Inaccurately high counts in 
Figure 7.6b are due to both 1) ringing in the single photon IRF and 2) compounded 
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baseline drift due to pulse pile up given the ringing waveform. Both effects are seen in 
the raw data within 7.6b. Figure 7.6c shows the image from 7.6b following digital high-
pass filtering to help correct for baseline drift. While closer to the ground truth (7.6a) 
than 7.6b, the presence of ringing (data inset) yields inaccurately high count rates in 
addition to a blurring of the image along the fast scan axis. Figure 7.6d shows the 
recovered image following LDA + HP digital filtering. While the image retains some 
blurring artifacts along the fast mirror axis, visual inspection shows significant 
improvement relative to 7.6c. Additionally, the data inset shows the removal of the 
ringing waveform following application of the digital filter.  
The presence of two peaks of opposite sign and disparate magnitude in the LDA-
derived digital filter (Figure 7.5b) yields insight into the likely mechanism of action of 
the filter. The relative magnitudes of the two peaks in the filter function likely work to 
give a near-zero dot product when overlapped with most peaks in the ringing IRF. I.e., in 
regions where the peak heights in the ringing IRF decay linearly with time (peaks at later 
time points), the constant magnitude ratio between the two peaks in the filter enables 
similar-valued integrals between the smaller-magnitude peak in the filter function 
(overlapped with a larger peak in the IRF) and the oppositely-signed larger-magnitude 
peak in the filter function (overlapped with a small peak in the IRF). The filter thus 
removes smaller magnitude peaks in the ringing IRF. It is proposed that the assumption 
of linearity in the IRF peak height decay is least valid for the first ~2 peaks in the IRF. 
This leads to a non-zero dot product when the filter function reaches this part of the IRF 




Comparison of LDA-based digital filtering with other techniques to increase the 
LDR of photon counting measurements was assessed through simulations of the ringing 
IRF across several orders of magnitude of photon count rates. The results are summarized 
in Figure 7.7. Photon counting after application of only a HP filter (removal of rolling 
background but retention of ringing in the IRF) yields inaccurately high count rates due 
to multiple peaks registering above the threshold for a single photon event. Pulse pile up 
also leads to saturation of the counting regime at ~5 Mcps. Imposing a dead time 
following a counting event (paralysis) recovers the true photon count at low count rates, 
as the dead time is selected considering knowledge of the IRF. Unfortunately, the LDR of 
paralysis is severely limited, as only count rates above ~100 kcps show bias due to 
photons arriving within the detector dead time. In contrast, the LDA + HP digital filter 
recovers accurate count rates up to ~50 Mcps, demonstrating an improvement in the LDR 
of the photon counting measurement.  
Digital filtering lowered the overall SNR of the measurement (as anticipated), due 
to diminished high frequency content (decreased peak integrated area) in the filtered data. 
This is evidenced by the model data shown in Figure 7.3, as the calculated SNR (defined 
here as the peak voltage divided by the standard deviation of the background) for peaks 
there-in dropped from 65 in the unfiltered data to 22 following digital filtering. 
Fortunately, in the assumption that the SNR is still sufficiently high to enable photon-
counting, such a loss in the overall SNR is not anticipated to be problematic, as 
information such as peak heights is not retained in traditional photon counting methods. 
Indeed, the ability to recover temporal impulses and the associated increase in the LDR 
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and accuracy of photon arrival times of the measurement (Figures 7.3 and 7.5) offsets the 
SNR decrease.  
The recovery of a deconvolved time-trace by LDA-based digital was compared to 
two alternative strategies: nonlinear curve fitting and Richardson-Lucy digital 
deconvolution. Nonlinear peak-fitting of the data using standard approaches from 
spectroscopy and chromatography can suppress the background noise and provide the 
origins of overlapping peaks more accurately than digital deconvolution in most 
instances. However, peak fitting is an iterative procedure requiring initial guess values, 
complicating application for streaming data analysis. Furthermore, peak-fitting requires 
the a priori assumption of a known functional form for the peaks. Preliminary estimates 
based on optimized algorithms in MatLab suggest fitting times of 1.7 s per photon event 
for the fitting of a single ringing waveform, corresponding to approximately 5 days to 
process each frame in a video rate acquisition with a mean of 0.05 photons per pulse. 
Alternative digital deconvolution approaches were also assessed, based on the iterative 
Richardson-Lucy deconvolution algorithm. As with many deconvolution approaches, the 
Richardson-Lucy algorithm requires a priori determination of the noise free instrument 
response function. In general, deconvolution with the Richardson-Lucy approach 
recovered impulse responses with comparable or higher signal to noise than the LDA-
based approach, but at the expense of considerable additional computational time. 
Preliminary assessments using Matlab built-in algorithms required between 10 s to 100 
s per data point on average to perform the deconvolution, corresponding to a little more 
than 8 seconds to roughly a minute per frame. While reasonable for a single frame of 
acquired data, the need for at least 8 seconds to perform the data analysis represents a 
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significant gap to bridge relative to the 15 fps data acquisition rate. From this analysis, 
the long times required for nonlinear curve fitting and for iterative deconvolution using 
the Richardson-Lucy algorithm are incompatible with real-time data analysis at the 
experimental 80 MHz repetition rate for each channel. 
Clearly, the improvements afforded by deconvolution must also be weighed 
against the computational costs associated with the data processing based on the 
particular application. For real-time data processing at the high data throughput rates used 
in this study, digital filtering arguably represents the fastest approach for performing 
digital deconvolution in terms of computational cost. Direct digital filtering for 
deconvolution can be performed in as little as 2 clock cycles of a FPGA when 
parallelized.16 FPGA clock speeds in the hundreds of MHz are currently available,  
allowing direct real-time analysis at data throughput rates exceeding the 80 MHz 
acquisition rates of the present study.  However, there is still an initial expense associated 
with the design of the appropriate digital filter. The LDA approach described herein 
requires significant training to reduce the noise inherent in the filter function. Provided 
the impulse response function does not change substantially over the time-course of a 
measurement as in the photon counting applications described herein, this initial 
investment may be easily justified by enabling subsequent high speed data analysis 
through simple digital filtering.  
It is significant that one LDA algorithm performed reasonably well for multiple 
very different impulse response functions. No explicit models were required for treating 
the measurement noise or the variance in signal intensities. All of these effects were 
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implicitly incorporated into the algorithm through the training set used to produce the 
LDA filters.  
7.5 Conclusions 
A novel digital filter derived from two class LDA has been shown to increase the 
LDA of photon counting measurements by over an order of magnitude. The filter is 
created through defining temporally coincident (class 1) and non-coincident (class 2) 
voltage transients, with the Fisher discriminant serving directly as the filter function. 
Following training, the digital filter can be used to recover a temporal impulse in raw data 
from a variety of IRFs. The digital filter was validated through both simulated photon 
counting measurements as well as experimental TPE-UVF images. With additional 
engineering efforts  for implementation via FPGAs, the algorithms proposed here-in have 
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Figure 7.1 Illustration of the process of digital filtering. The dot product between the 
signal (blue) and the digital filter (red) yields a scalar value coincident with the origin of 
the filter. By sliding this dot product along the length of the data, the filtered data (green) 




Figure 7.2 Generation of the digital filter from 2 class LDA. Temporally coincident (left 
column) and non-coincident (right column) voltage transients make up the two classes. 
LDA allows recovery of the Fisher discriminant (below left) which is used directly as the 





Figure 7.3 Model data at a variety of photon flux rates showing the recovery of temporal 
impulses (blue) from the raw data (red). Removal of voltage transient overlap by LDA 





Figure 7.4 Receiver operating characteristic curve for LDA filtered data. Given 
appropriate threshold settings, the error rate is relatively low even at very high photon 






Figure 7.5 Application of the LDA digital filter to correct for a ringing waveform. A) 
ringing waveform created through impedance mismatch in the ADC. B) LDA-derived 
digital filter. C) Raw data (red), LDA-digital filtered data (green) and LDA digital 
filtered data after high-pass filtering to remove rolling background features (blue). 






Figure 7.6 Experimental TPE-UVF images of L-Tryptophan. A) Ground truth image 
from an impedance-matched data channel. Inset: raw time domain data. B) Raw image 
from impedance mismatched channel. Inset: raw time domain data showing ringing 
artifacts. C) Image from B) following high-pass filtering to remove baseline drift. Inset: 
raw time domain data showing reduction in baseline drift, but retaining significant 
ringing artifacts. D) Image from C) following LDA digital filtering. Inset: raw time 





Figure 7.7 Summary to simulations to asses the LDR of LDA digital filtering. A common 
approach for pulse pile up correction (paralysis) is shown in green, which recovers the 
true number of photons only at very low count rates. High-pass filtering only is shown in 
blue. Due to ringing present in the IRF, high-pass filtering alone significantly over-
estimates the count rate. LDA plus high-pass digital filtering is shown in red, exhibiting a 
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Finding the Needle in the Haystack: Characterization of
Trace Crystallinity in a Commercial Formulation of Paclitaxel
Protein-Bound Particles by Raman Spectroscopy Enabled
by Second Harmonic Generation Microscopy
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ABSTRACT: Second harmonic generation (SHG) microscopy
was used to rapidly identify regions of interest for localized
confocal Raman spectroscopy measurements in order to
quantify crystallinity within lyophilized Abraxane powder
(protein bound paclitaxel for injectable suspension). Water
insoluble noncentrosymmetric crystalline particles ranging from
∼1 to 120 μm were identified by SHG, with wide variability
in crystal size and frequency observed between several batches
of Abraxane. By targeting the Raman analysis to these localized
regions identified by SHG, the required measurement time
was decreased over 2 orders of magnitude, from 8 h to 2 s.
Experimental Raman spectra of SHG active domains in
Abraxane were in good agreement with experimental spectra
of pure crystalline paclitaxel. These collective results are consistent with up to 30% of the active ingredient being present as poorly
soluble crystalline particulates in some batches of Abraxane.
KEYWORDS: second harmonic generation, amorphous formulations, nanosuspensions, Raman spectroscopy, microscopy, paclitaxel,
Abraxane, lyophilization
■ INTRODUCTION
Modern drug discovery frequently identifies active pharmaceut-
ical ingredients (APIs) that are highly effective against the disease
target but that are hard to deliver to the biomedical target.
Increasingly, new compounds exhibit low aqueous solubility,
whereby it is estimated that some 40% of new chemical entities
are discarded for this reason.1 Many solubilization strategies are
designed to address this issue. One of the most common
methods toward this end is the preparation of amorphous
formulations in which the API is molecularly dispersed in a
noncrystalline highly soluble matrix to increase the dissolution
rate and transient concentration.2−10 Unfortunately, most such
formulations are inherently metastable and run the risk of
spontaneously transitioning to their more thermodynamically
stable crystalline form. If such phase changes occur either in the
formulation preparation or during storage, significant reductions
in drug bioavailability may arise.
For intravenous (IV) formulations, incomplete solubilization
of the API introduces additional embolism risks associated
with blood vessel occlusion by circulation of poorly soluble API
particulates. Therefore, various different strategies to solubilize
APIs are employed, including pH adjustment and/or the use
of cosolvents, surfactants, or emulsifiers.11−13 Unfortunately,
additives used to solubilize drugs for IV formulations can exhibit
toxicity,14,15 in some cases fatal.16 Therefore, solubilization
strategies that minimize the use of additives with undesirable
side-effects are of great interest. Recently, nanosuspensions17−20
such as nanoparticle albumin-bound (NAB) paclitaxel16 have
been found to offer a potentially promising solution to this
problem. NAB paclitaxel (PTX) is manufactured through
coprecipitation with human serum albumin (HSA), leading to
an amorphous formulation.16 Upon reconstitution, this formula-
tion is a nanosuspension containing particles ca. 130 nm in
diameter.
Quantification and detection of crystallinity at low levels within
such an amorphous formulation is often a defining measurement
for predicting the long-term success of the product. For IV
formulations in particular, crystal formation is detrimental because
it not only reduces the solubility advantage of the amorphous
formulation, but the presence of large, insoluble particulates is
problematic and hence subject to stringent regulations.13,21,22
Unfortunately, for potent APIs at low loadings, accurate
determination of crystallinity poses a significant measurement
challenge. As the drug loading approaches the detection limits
of conventional benchtop methods, even major differences in
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relative drug crystallinity become difficult to distinguish with
statistical confidence. Commonly used methods for crystal
detection and characterization in the drug formulation pipeline
include X-ray powder diffraction (PXRD), differential scanning
calorimetry (DSC),23 Raman spectroscopy,24,25 scanning electron
microscopy (SEM),26,27 hot stage microscopy,28 and solid-state
nuclear magnetic resonance spectroscopy (SSNMR).29 However,
most of these techniques do not typically exhibit detection limits
for crystallinity significantly lower than ∼1%, in most cases
because of background noise from the much larger noncrystalline
fraction. Additionally, the composition of NAB PTX makes
assessment by several of these methods problematic. The use
of HSA as the formulation matrix would make detection of
crystallinity by DSC difficult due to the low denaturation
temperature of the protein matrix. While SEM has been used in
accelerated stability studies of amorphous formulations,26,27
several limitations complicate its application toward the analysis
of bulk NAB PTX. As a surface characterization tool, the use
of SEM for monitoring crystallization is generally limited to
crystallization events taking place on the formulation’s exterior or
within a thin film, making characterization of a powdered, bulk
material more difficult.
With detection limits for crystallinity approximately an order-
of-magnitude lower than mentioned above, SSNMR has been
used to quantify and characterize crystalline content within
a variety of powdered samples.30−33 SSNMR characterization
of NAB PTX was previously performed in the course of patent
litigation (Elan Pharma International Ltd. v. Abraxis BioScience
Inc., United States District Court for the District of Delaware)
in 2008.34,35
Nonlinear optical (NLO) microscopy, in particular second
harmonic generation (SHG), has recently emerged as a com-
plementary technique for the rapid detection and quantification
of trace crystallinity within pharmaceutical materials.36−41
Coherent SHG selectively arises exclusively from the bulk
crystalline fraction and only within crystals of appropriate
symmetry. The chirality inherent in most new pharmaceutical
APIs largely guarantees that the crystals produced will be
bulk-allowed for SHG. This selectivity for crystalline API has
allowed measurements with detection limits on the order of
parts per billion to as low as parts per trillion ranges under
favorable conditions.42
Despite the low detection limits of SHG microscopy, the
SHG intensity itself provides little significant chemical informa-
tion about the composition of the SHG-active source. In the
present study, efforts were undertaken to lower the detection
limits of Raman spectroscopy through targeted analysis
guided by SHG imaging. In brief, targeting Raman analysis to
regions of interest preidentified by SHG minimizes the volume
of additional material that must be probed in conventional
chemical imaging modalities.
In the present study, assessment of this SHG-guided analysis
approach was performed for the amorphous IV formulation
Abraxane (nanoparticle albumin bound paclitaxel for injectable
suspension). Abraxane was the first nanosuspension approved for
clinical use13,16 and is indicated to contain 10% (w/w) PTX
bound to nanoparticles of HSA. Abraxane has been shown
to have increased efficacy compared to other PTX formula-
tions (e.g., Taxol), particularly in the treatment of breast
cancer,16,43,44 nonsmall cell lung cancer,45−48 and pancreatic
carcinoma.49 PTX is generally regarded as exhibiting
substantial solubility limitations, with crystalline PTX exhibit-
ing poor bioavailability.13 In addition to the increased apparent
solubility arising from an amorphous nanosuspension, it is
thought that Abraxane achieves higher treatment specificity
as a result of its HSA matrix, utilizing the known high protein
uptake rate of tumors.20,50−52
■ METHODS
Abraxane samples were analyzed in their native (solid) form
as obtained from the manufacturer. Four different batches
were imaged (lot numbers: 6106359, 6106934, 6107014, and
6107321, batches 1−4 respectively). SHG images were
acquired with a commercial SONICC (second-order nonlinear
optical imaging of chiral crystals) microscope (Formulatrix, Inc.).
The system contains a Fianium FemtoPower laser (1060 nm,
1.3 W power output), with a 51 MHz repetition rate and a
166 fs pulse width. The instrument uses resonant mirror/
galvanometer beam scanning (8 kHz fast axis) to generate
images. Unless otherwise stated, all SONICC images were
acquired with 250 mW infrared (IR) power at the sample, with
a 2 s image acquisition time. SHG light was collected in the
transmission direction, requiring the preparation of thin samples
to minimize scattering losses. In brief, samples were prepared by
placing a small aliquot of powder between two glass coverslips,
within a thin (∼100 μm) spacer to ensure uniform sample
thickness.53 Twelve fields of view (FOV) were obtained for each
sample and used to generate particle histograms. The fraction
imaged by SHG represents approximately 1% of the 1 g bulk
sample, and a total volume probed of 2.2 mm3 (12 fields of view
with dimensions of 1925 μm × 1925 μm × 50 μm). For analysis
of relative PTX crystallinity in batch 1, physical mixtures of
crystalline PTX in HSA (Attix Pharmaceuticals) (0.1−5% drug
loading) were prepared as standards for a calibration curve.
Given the 10% (w/w) loading of PTX in Abraxane, these
standards correspond to 1−50% relative crystallinity of the PTX.
While it is possible the PTX used to create the calibration curve
Figure 1. SHG images of batches 1−4 (A−D, respectively) of
Abraxane. Insets show line scans across an individual crystalline
domain for each image, in units of megacounts per second (Mcps).
All images are shown on the same brightness scale. Large variations in
crystallinity are readily apparent.
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standards differs in crystal form from the PTX present within
Abraxane, the two most common hydrate crystal forms listed in
the Cambridge Structural Database (i.e., neglecting nonaqueous
solvates) are of the same crystalline space group with nearly
identical lattice constants. Among crystals of identical building
blocks, the average observable SHG intensity is dictated
primarily by the crystalline space group. In the case of these
two hydrates (entry IDs RIGLAW and RIGKUP), the average
observable SHG intensities are assumed to be identical.
Raman images were acquired on an alpha300 AR commercial
confocal reflectance Raman microscope (WITec) with a 633 nm
HeNe source and 35 mW output (Melles Griot). A 10×
objective (0.25 NA) was used, giving a beam waist of 0.8 μm
and a depth of field of 20 μm. WITec Control 1.60 was used
for data collection. Specific fields of view (300 μm × 300 μm)
containing a region of interest within the bulk powdered sample
were first located via SHG and then marked for subsequent
confocal Raman analysis. With the crystalline domain located
at the center of the marked 300 μm × 300 μm FOV, reposi-
tioning on the Raman microscope via bright field imaging was
quite reproducible, allowing the crystallite to be located via
spectral analysis with minimal searching. Each spectrum was
acquired with 4 min of integration time, followed by high-pass
digital filtering to remove fluorescence background. Bench top
powder X-ray diffraction (PXRD) was acquired on a Rigaku
SmartLab diffractometer (0.1544 nm wavelength) scanned at
one degree/min.
■ RESULTS AND DISCUSSION
Figure 1 shows SHG images of four different batches (varying
lot numbers) of Abraxane. A representative SHG image of pure
HSA (negative control) is shown in the Supporting Information,
Figure SI-1. Samples were imaged in powdered form, as received
from the manufacturer. All images are shown on the same
brightness scale. Insets show line scans across a single particle
in each batch in units of megacounts per second (Mcps).
High variation in crystallinity and particle number/size between
batches is readily observed.
A sample from batch 1 was imaged with SHG both before
and after dissolution in ultrapure water, the results of which are
shown in Figure 2. This experiment was performed primarily to
exclude possible SHG interferences from the relatively small
fraction of buffer salts known to form noncentrosymmetric and
therefore SHG-active crystals.54 It would not be unreasonable
for salts to exist within the formulation given the use of
HSA as the matrix. However, all such compounds are highly
water-soluble and would not be expected to remain following
addition of water to the sample. Furthermore, solubilization
in water mirrors the recommended procedure in preparation
for parenteral introduction. Figure 2 summarizes these results,
showing a bright field image of Abraxane in the solid state (a),
bright field and cross-polarized images of individual crystallites
within Abraxane suspension (b), and SHG images of solid-
state and suspended Abraxane (c and d, respectively). SHG
active areas remained even after dissolution in ultrapure water
combined with vigorous mixing, suggesting that the SHG-active
material exhibited poor aqueous solubility and was unlikely to
be an SHG-active buffer salt. Additionally, these crystallites are
likely to remain unsolubilized within Abraxane suspension.
Figure 2. Bright field (A,Bi and Biii), cross-polarized (Bii, Biv), and
SHG (C−D) images of Abraxane before and after dissolution in
ultrapure water followed by rigorous mixing. Results show that SHG
active regions exhibit poor aqueous solubility. In addition to this direct
assessment of formulation solubility, these results indicate that the
SHG active regions are unlikely to arise from water-soluble non-
centrosymmetric buffer salts.
Figure 3. SHG image (A) and corresponding confocal Raman spectra after digital high-pass filtering (B). The blue and red traces shown in B were
taken at the indicated locations of regions I and II, respectively. For comparison, the black and green traces show the experimental spectra of pure
PTX and pure HSA (blank), respectively. Experimental spectra for pure PTX and for SHG active domains in Abraxane agree well. High SNR present
at 1007.1 and 1604.3 cm−1 within these two spectra is consistent with higher local PTX concentration within an SHG active domain of Abraxane.
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Additional confocal Raman measurements were performed
selectively on the regions of interest identified as the SHG-
active domains in the native Abraxane dosage form, the results
of which are summarized in Figure 3. With initial screening
by SHG, a crystalline domain of interest (∼20 μm diameter)
within a 300 μm × 300 μm FOV was marked for subsequent
analysis, shown in Figure 3a. Figure 3b summarizes the experi-
mental Raman spectra acquired within the region of interest
and elsewhere in the FOV. For comparison, the experimental
Raman spectra of pure PTX and pure HSA are also shown.
The Raman spectrum acquired from the SHG-active region of
interest agrees remarkably well with the measured spectrum
of pure crystalline PTX. Furthermore, the peak heights were
notably greater in the SHG-active region, consistent with a
higher local concentration of PTX relative to other locations
within the formulation. In addition, the two peaks at 1007.1 and
1604.3 cm−1 are most pronounced in the crystalline PTX spectrum,
as well as in that of the SHG-active region, but are only marginally
detectable in other locations within the formulation.
If the SHG-active and poorly soluble fraction of material in
Abraxane is attributed to PTX, SHG microscopy can be used
to estimate the relative crystallinity of the active ingredient
within the formulation. A calibration curve of SHG signal was
constructed from physical mixtures of crystalline PTX in HSA at
various loadings, accounting for the 10% (w/w) loading of PTX
in Abraxane. The PTX within batch 1 was found to be 30 ± 13%
(95% CI) crystalline, corresponding to 3.0% overall crystallinity
in the measured lot of Abraxane. The relatively large uncertainty
in the crystallinity arose primarily from the limited volumes
of materials probed, resulting in statistical fluctuations in the
crystalline fraction per probed volume. Such a large fraction of
PTX present in a crystalline state may potentially impact the
effective dose of the formulation. Analysis by PXRD failed to
show any peaks, consistent with these relatively low levels of
crystallinity. A representative PXRD pattern is shown in the
Supporting Information, Figure SI-2.
The spatial information afforded by SHG also allows assess-
ment of the size distribution of poorly soluble particulates
in situ within the final dosage forms. Histograms of SHG-active
particle sizes are shown in Figure 4 for batches 1, 3, and 4 (a−c,
respectively) as batch 2 did not contain enough particles to
produce a meaningful histogram. From these results, different
lots exhibited diverse distributions, with particle size ranging
from <10 μm to over 120 μm. As the mass fraction probed by
SHG represents approximately 1% of the container contents,
the observation of 37 particles greater than 26 μm within the
imaged fraction of batch 1 suggests approximately 3700 (±600)
particles >26 μm present within the final dosage form, with
the determined standard deviation based on Poisson statistics.
This degree of direct access to the size distribution of insoluble
crystalline particles would be challenging to obtain in situ within
the solid-state final dosage form using alternative standard
methods given the optical opacity of the Abraxane formulation
but is reasonably straightforward to access by SHG imaging.
This initial screening by SHG greatly reduced the time required
to perform the Raman measurements. For a typical line-scan
commercial Raman imaging approach, the laser power required
to obtain the SNR present in Figure 3 for a 256 pixel laser
line would be approximately 9 W. In the assumption that this
power does not represent a laser-limited measurement and
by decreasing the per pixel integration time to 30 s (acceptable
minimum SNR for identification), it would take approximately
8 h of continuous data acquisition to map out a given field of
view with equivalent (512 × 512) resolution, compared to
2 s/FOV used for the SHG images. This represents a reduction
in the measurement time of over 2 orders of magnitude. It is
further of note that the SNR present in these SHG images
(∼500 for the line scan in Figure 1a) could be equivalently
reduced, decreasing the required SHG measurement time well
into the video-rate regime.
■ CONCLUSIONS
Using SHG microscopy to identify regions of interest within
an amorphous pharmaceutical formulation was found to enable
targeted analysis by Raman spectroscopy. By guiding Raman
measurements to only these regions of interest, the measure-
ment time was reduced by over 2 orders of magnitude relative
Figure 4. Histograms of crystal size for batches 1, 3, and 4 of Abraxane
(A−C, respectively) with occurrence reported as particle number
density. Not enough crystallites were present in batch 2 to produce a
meaningful histogram. Insets show higher size ranges. Crystals up to
120 μm are present in Abraxane, with substantial variability in particle
density and size between the measured batches.
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to established benchtop instruments. Characterization of the
amorphous nanosuspension Abraxane illustrated this process
for a drug formulation currently in clinical use. Substantial
variability in relative crystallinity was observed within the pro-
duct as-received, with water-insoluble particles up to 120 μm
observed in the formulation. SHG-guided analysis by Raman
spectroscopy was consistent with crystalline paclitaxel compris-
ing the poorly soluble particles. These combined results
illustrate the potential benefits provided by the marriage of
the rapid and highly selective technique of SHG with
information-rich spectroscopic methods such as Raman.
■ ASSOCIATED CONTENT
*S Supporting Information
Representative SHG image of pure (unloaded) human serum
albumin as a negative control, typical powder X-ray diffraction
pattern of Abraxane. The Supporting Information is available
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ABSTRACT: The use of nonlinear optical Stokes ellipso-
metric (NOSE) microscopy for rapid discrimination of two
polymorphic forms of the small molecule D-mannitol is
presented. Fast (8 MHz) polarization modulated beam-
scanning microscopy and a recently developed iterative,
nonlinear least-squares fitting algorithm were combined to
allow discrimination of orthorhombic and monoclinic crystal
structures of D-mannitol with data acquisition times of <7 s per
field of view with a signal-to-noise ratio (SNR) of ∼300.
Discrimination between polymorphic forms within the 99.99%
confidence interval was achieved by standard statistical tests of
the recovered probability density functions for the measured observables following two class linear discriminant analysis. These
measurements target bottlenecks in small-volume, high-throughput solid form screening experiments for polymorph discovery in
the development of emerging active pharmaceutical ingredients.
Polymorphism, or the presence of multiple crystal forms fora single molecular building block, is an important
characteristic in the development of therapeutic small
molecules.1−5 As different polymorphs and crystal forms can
exhibit widely varying physiochemical properties, including
overall formulation stability and drug solubility, precise control
over crystal form can be critical for reliable drug performance
and product quality control.1,2,6−8 Additionally, a thorough
characterization of generally accessible polymorph and cocrystal
forms is typically performed prior to establishing intellectual
property rights on pharmaceutical formulations.9,10 The
importance of control over drug polymorphic form is perhaps
best illustrated by the 1998 recall of Norvir (oral capsule
formulation of the HIV protease inhibitor ritonavir) upon
discovery of a more thermodynamically stable polymorphic
form with decreased oral bioavailability.11 As a result of these
motivations, drug development laboratories spend considerable
resources on discovering and characterizing the polymorphic
forms of an emerging active pharmaceutical ingredient
(API).12−14
Trends in the pharmaceutical industry are shifting crystal
form analysis to earlier stages in the pipelines, targeting analysis
of a greater diversity of samples to test with ever smaller
quantities of purified product available for testing. High-
throughput (HT) crystallization procedures intended to
empirically map polymorphic space for a new drug candidate
are playing an increasingly important role in new form
discovery.8,15−17 While the parallel approach of HT crystal-
lization technology offers an overall time savings over
traditional serial “batch” approaches, the characterization of
all crystal forms within multiwell plate crystallizations
represents a nontrivial measurement task as the available
mass of purified materials are reduced. Techniques such as
Raman spectroscopy,18−21 Fourier transform infrared spectros-
copy (FT-IR),22 powder X-ray diffraction (PXRD),16,18,20,23
differential scanning calorimetry (DSC),18 and optical micros-
copy8,16,20 are currently used to assess the polymorphic form of
hits. Unfortunately, the time required for characterization by
these methods creates a bottleneck in the screening process
that is ultimately limiting the number of screenable conditions.
While Raman spectroscopy generally provides shorter charac-
terization times (a few sec/measurement)20 relative to other
techniques such as PXRD (current state of the art requires ∼60
s/measurement using benchtop systems),16 the overall time
required to analyze the results of several thousand crystal-
lization experiments routinely limits the number of trials that
can be prepared and run. This disparity is often compounded
by the need for characterization by more than one analytical
method, such that completion of a HT study for a new drug
candidate can take several weeks to complete.8 The analysis of
already known crystal forms may occupy a large portion of this
characterization time. Furthermore, the existing measurement
time bottleneck is only likely to pose even greater challenges for
throughput as the decreased crystal mass in each well in high-
throughput screens lowers the overall SNR in the measure-
ments. Additionally, preferred orientation effects become
increasingly important in small samples as the finite set of
crystals results in a stochastic set of discrete crystal
orientations.24,25 Preferred orientation can significantly com-
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plicate automated analysis of the observed spectra;8 rotation is a
nonlinear operation, such that the measured Raman spectra and
XRD patterns produced from nonrepresentative sampling
generally cannot be expressed as simple linear combinations
of pure components. As a result, linear decomposition methods
of the spectra such as principal component analysis and linear
discriminant analysis are often intractable. A need has thus
emerged for additional complementary characterization ap-
proaches that can decrease characterization times for trace
quantities of material in HT new crystal form discovery.
Second harmonic generation (SHG) has been suggested as
an alternative method for crystal polymorph determination. In
studies by Rades et al., differences in the angle-dependent SHG
scattering were linked to changes in crystal form.26 However,
conventional powder analysis by SHG is limited primarily to
differences in the overall intensity produced by a powder,27,28
which provides fairly small discriminatory capability, requires
sufficiently large samples to provide representative sampling as
in XRD and Raman, and is highly dependent on crystal size
effects.29,30 Nonlinear optical Stokes ellipsometry (NOSE),
combining rapid (8 MHz) polarization modulation of the
incident beam and polarized detection of the second harmonic,
has recently been shown as a measurement technique sensitive
to small molecule crystal orientation,31−33 increasing the
information content of previous SHG microscopy studies.34
Although not explored in these previous studies, NOSE has the
potential to alleviate measurement bottlenecks found in HT
crystallization studies through the Boolean discrimination and
subsequent removal of already-discovered crystal forms from
more time-consuming analysis pipelines. Because NOSE is
based on polarization-dependent measurements, it has self-
referencing measurement advantages over SHG measurements
based on intensity alone. Additionally, recovery of individual
crystal orientations by NOSE microscopy allows tensor analysis
in the local-frame of the crystal, such that crystal form
determination can potentially be achieved even in samples
containing only a handful of microcrystals. Polymorphic
analysis by NOSE has the additional potential advantages of
being fast (approaching video-rate) and nondestructive.
Combining NOSE with birefringence and traditional optical
microscopy all acquired simultaneously on one platform also
opens up the possibility for the combination of multimodal
analyses.31
Here, we assess the potential merits of NOSE for rapid
crystal form discrimination using two polymorphic forms of the
small molecule D-mannitol. D-mannitol was selected as a model
system for several reasons. First, several polymorphic forms are
readily accessible via simple room-temperature recrystalliza-
tions.35 Additionally, D-mannitol is an exceedingly common
small-molecule excipient used in pharmaceutical formulations.
Disentanglement of crystal structure and orientation allows the
recovery of local (crystal) frame nonlinear optical tensor
elements describing the polarization-dependent SHG efficiency
for a given crystal. These unique tensor elements are one of
several quantities which serve as the experimental observable
for discrimination on a per-crystal basis. Polymorph discrim-
ination based on NOSE is shown for orthorhombic (P212121)
and monoclinic (P21) structures of D-mannitol. The potential
for discrimination was assessed from measurements of only ∼1
μg of material, consistent with sample masses found in small
volume HT crystallization studies.
■ MATERIALS AND METHODS
Experimental Section. D-mannitol was purchased from
Sigma-Aldrich. Orthorhombic and monoclinic forms of D-
mannitol were crystallized from different solvents according to
previously published protocols.36,37 The orthorhombic form
was recrystallized from 70/30 ethanol/water, and the
monoclinic form was obtained via an antisolvent crystallization
from 50/50 water/acetone. Powder X-ray diffraction (PXRD)
patterns were obtained on a Rigaku SmartLab X-ray
diffractometer, using a wavelength of 1.554 Å and a scan
speed of 0.6° 2θ/min. Acquired PXRD patterns were compared
to those predicted by Mercury (Cambridge Structural Database,
CSD).41 Entry IDs of CSD entries were DMANTL8
(orthorhombic) and DMANTL14 (monoclinic).
NOSE images were acquired on a custom microscope
capable of 8 MHz polarization modulation described in detail in
several previous publications.31,33 In brief, an 800 nm, 80 MHz,
100 fs Ti:sapphire laser (SpectraPhysics) at an average incident
power of 200 mW was used as the light source and focused
onto the sample using a 10×, 0.3 NA objective (Nikon). The
laser served as the master clock for the beam-scanning and data
acquisition electronics. The microscope utilized a resonant
mirror (∼8 kHz, EOPC)/ galvanometer mirror (Cambridge-
Tech) for beam scanning and PCI express digital oscilloscope
cards (AlazarTech) as the analog to digital converter (ADC).
SHG was separated from the fundamental via a series of
dichroic/band-pass optical filters, and photomultiplier tubes
(PMT) (Hamamatsu) were used as detectors. An electro-optic
modulator (EOM) was used for polarization modulation at 8
MHz (laser served as master clock), and was oriented at +45°
from its fast axis. Glan-Taylor polarizers (GTs) were placed
before the two PMTs (transmission direction), with a quarter
wave plate (QWP) oriented at +22.5° placed after the sample,
prior to the polarizer. A GT was also placed before a
photodiode (transmission direction) to allow polarized
detection of the laser fundamental.
Computational. Following image acquisition, Orienta-
tionJ38,39 (NIH ImageJ)40 and custom Matlab software were
used for analysis. ImageJ was used to threshold the SHG
images, allowing particle (crystal) analysis. The SHG intensity
for each input polarization was averaged across each individual
crystal. The 10 polarization-dependent responses are then
contracted down to a set of five Fourier coefficients via linear
least-squares fitting (Matlab) as described previously.31 These
Fourier coefficients are a function of both sample orientation
(described by Euler angles θ, ψ, and ϕ) and intrinsic
polarization-dependent nonlinear optical susceptibility. A
custom iterative, nonlinear least-squares fitting algorithm was
developed for the analysis of NOSE images. This algorithm has
been described in detail in related publications,32,33 and
recovers two unknown orientation angles (θ, ψ), the per-
crystal SHG intensity, and the values of the local-frame
nonlinear optical susceptibility tensor elements. For each crystal
in the image (particles identified via ImageJ), the in-plane
azimuthal rotation angle (ϕ) was measured with the
OrientationJ plug-in (NIH ImageJ). Images showing the
recovered values of ϕ for a sample field of view for both
polymorphs are shown in the Supporting Information, Figure
SI-2.
Following conversion of the Fourier coefficients to an
alternative set of polynomial coefficients,31 the coefficients and
in-plane orientation angles for each crystal were used as inputs
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into the iterative fitting algorithm. In the first step, a user-
defined set of local-frame nonlinear optical susceptibility tensor
elements and the in-plane orientation angle (recovered from
OrientationJ) were assumed, and a nonlinear least-squares fit of
the polynomial coefficients to recover the remaining two
orientation angles and the per-crystal SHG intensity was
performed. Following completion of the fit, the fitted values for
θ, ψ, and the per-crystal SHG intensity were assumed explicitly,
and an additional nonlinear least-squares fit to recover local-
frame tensor element values (constrained fit) was then
performed. This entire process was iterated until the system
converged. As described in the related publications,32,33 the
algorithm has been validated on both theoretical data of
multiple symmetries and thinly sectioned porcine/mouse
collagenous tissue samples. Due to sensitivity of the recovered
orientation angles on initial parameter guess values (i.e.,
equivalent solutions are found), the iterative algorithm was
subjected to 100 independent runs with randomized guess
values for θ and ψ. The mode of the recovered values for the
local-frame tensor elements and orientation angles for each
crystal was used for subsequent analyses.
The symmetry properties of the D-mannitol structures
studied herein yield 3 and 13 unique nonzero tensor elements
for the orthorhombic (P212121) and monoclinic (P21)
structures, respectively. Together with two orientation angles,
this yields 5 and 15 recovered variables, respectively, for the
measurement. As the number of recovered parameters for the
P21 structure exceeds the number of observables, direct
recovery of all unique nonzero tensor elements for the
monoclinic form is not anticipated to be accurate (high
covariance) and was thus not attempted. However, the goal of
this study is simply Boolean discrimination of orthorhombic
structures for the purpose of identifying common crystal forms.
Accordingly, NOSE measurements of both the monoclinic and
orthorhombic crystal structures were fit to the equations
describing the orthorhombic response to recover three unique
local-frame tensor elements (along with per-crystal SHG
intensities and two orientation angles) for each crystal
structure. Following 2-class linear discriminant analysis
(LDA) for optimal dimension reduction, statistical tests (F
test and t test) were then used to provide a quantitative means
of making the Boolean structure discrimination through
comparison of the probability density functions (pdfs) giving
rise to the responses for the “known” form (orthorhombic) and
the “unknown” form (monoclinic).
■ RESULTS AND DISCUSSION
D-mannitol was crystallized into two polymorphic forms via
recrystallization from common solvents. These two forms adopt
orthorhombic (P212121) and monoclinic (P21) symmetries.
Confirmation of the two crystal structures was performed via
PXRD. Figure 1 contains the observed diffraction data together
with the predicted patterns from the Cambridge Structural
Database (CSD)41 for both the orthorhombic (CSD ID
DMANTL8) and monoclinic (CSD ID DMANTL14) crystal
forms, based on the reported lattice constants and nuclear
electron densities. Although there are some disparities in the
relative peak heights, excellent agreement between most 2θ
diffraction angles is generally observed.
NOSE colormaps of orthorhombic (left column) and
monoclinic (right column) forms of D-mannitol are shown in
Figure 2 for both the horizontally polarized PMT (H PMT)
Figure 1. Experimental (solid trace) and predicted (dotted trace) PXRD patterns for orthorhombic (blue, bottom) and monoclinic (red, top) crystal
structures of D-mannitol. Patterns are artificially offset vertically for clarity. Predicted patterns were obtained from the Cambridge Structural Database
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and the vertically polarized PMT (V PMT). NOSE colormaps
are created through linear fitting of the n-polarized SHG
intensities to a set of five Fourier coefficients, as described
previously and shown in eq 1.
= + Δ + Δ + Δ
+ Δ
ωI a b c d
e
cos(2 ) cos( ) sin( )
sin(2 )




The polarization state of the incident light emerging from the
EOM is dependent on the phase shift Δ in eq 1, with the values
of a−e Fourier coefficients shown as merged red, green, blue,
cyan, and magenta (RGBCM) images in Figure 2. The relative
magnitude of each coefficient (a−e) provides the color
weighting (RGBCM, respectively) within each pixel of the
image. These images thus contain all polarization-dependent
NLO information recovered from the measurement. Example
single color Fourier coefficient images are shown in the
Supporting Information (Figure SI-1). As described previ-
ously,31 further analyses are performed following linear
conversion of the above Fourier coefficients to an alternative
set of polynomial coefficients. While the images shown in
Figure 2 were obtained through linear fitting on a per-pixel
basis for ease in visualization, the subsequent data analysis
presented herein involved linear fitting after averaging the
polarization-dependent SHG response across each individual
crystal. The amplitudes of the Fourier coefficients depend upon
both the inherent polarization-dependent SHG activity and the
orientation of each crystal within the field of view. The inherent
polarization-dependent SHG activity for a crystal is described
by a rank 3 tensor, where each scalar entry describes the
efficiency and relative phase of frequency doubling given
defined polarizations for both the incident and the exiting fields.
SHG expressed in the local Cartesian frame for the crystal can
yield as many as 18 unique nonzero tensor elements for a
material. However, many of these tensor elements are equal or
zero-valued by symmetry, with higher symmetry materials
containing more zero-valued and non-unique entries.
The first method assessed for discrimination was based on
statistical analysis of the directly recovered Fourier coefficients.
Figure 2. NOSE colormaps for two structures of D-mannitol. Values of
a−e from eq 1 are shown as a merged RGBCM image for each of two
photo detectors (horizontally and vertically polarized PMTs). The
values of a−e collectively describe all polarization-dependent nonlinear
optical properties of the sample, including the combined effects of
both inherent polarization-dependent SHG activity and crystal
orientation within the field of view.
Figure 3. Histograms following two-class linear discriminant analysis of the raw polynomial coefficients for orthorhombic (blue) and monoclinic
(red) forms of D-mannitol. The means of the recovered distributions fail a t test with >99.99% confidence.
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Two-class linear discriminant analysis (LDA) was performed on
these coefficients. These results are summarized in Figure 3.
Following projection onto the Fischer discriminant, histograms
of the pooled response from crystals of each structure were
constructed to visually compare separation of the probability
density functions (pdfs). The data were also compared via a
conventional F test and t test to quantitatively assess statistical
independence of the variances and means (respectively) of the
two experimental distributions. The t test was only performed if
the distributions first pass the F test, indicating that the
variances in the compared data are not statistically distinguish-
able with 99.99% confidence. Figure 3 shows a histogram of the
raw coefficients following LDA for the orthorhombic (blue)
and monoclinic (red) structures. Calculated values for the F
and t tests are shown in Table 1, with green indicating a pass
and red indicating a failure of the test.
Two different contributions to the separation were
considered; changes in the polarization-dependence and
differences in the orientation-corrected, per-crystal SHG
intensities. The raw coefficients giving rise to the histograms
shown in Figure 3 vary in response to changes in all of these
quantities. To aid in understanding the role of the orientation-
corrected, per-crystal SHG intensities in driving the separation
of these distributions, the raw polynomial coefficients in Figure
3 were intensity-normalized through division by the per-crystal
intensity values found via the iterative, nonlinear least-squares
fitting algorithm. Figure 4a shows histograms of the projected
coefficients after intensity-normalization. Additionally, histo-
grams of these orientation-corrected intensity values are shown
directly in Figure 4b. Calculated F and t values are shown in
Table 1.
All statistical tests presented herein assume a 99.99%
confidence interval. In brief, the recovered distributions
following LDA of the raw polynomial coefficients pass the F
test but fail the t test, indicating that the pdfs giving rise to
these distributions have statistically independent means within
the 99.99% confidence interval. The intensity-normalized
polynomial coefficients pass both the F and the t tests (i.e.,
no statistically significant discrimination at the given confidence
interval can be achieved in either the variance or the mean
projected along the LDA axis). From inspection of the color
maps (Figure 2), it is clear that in-plane orientation of the
crystals contributes significantly to the diversity of polarization-
dependent responses observed in the laboratory frame.
To disentangle the effects of laboratory-frame crystal
orientation from those of inherent local-frame polarization
dependence of the crystals, the above analyses were repeated
for the local-frame tensor elements obtained via the iterative,
nonlinear least-squares fitting algorithm. These results are
summarized in Figures 5 and 6. Figure 5 shows histograms of
the raw local-frame tensor elements obtained for each crystal
structure, with the calculated F value shown in Table 1. The
orientation-corrected intensities obtained via nonlinear least-
squares analysis (Figure 4b) can also be included when
analyzing the distributions of the local-frame tensor elements.
For visualization purposes, a scatter plot showing the local-
frame tensor elements for each crystal form after multiplication
by the per-crystal intensities recovered via the iterative
nonlinear least-squares analysis is given in Figure 6a. The
larger variance of the monoclinic structures relative to the
orthorhombic structures is readily observed. Figure 6b shows a
histogram of the data in Figure 6a following LDA. The
Table 1. Summary of Statistical Testsa
aGreen shading indicates a pass, red shading indicates a failure.
Figure 4. Histograms for the intensity-normalized polynomial coefficients following LDA (A) and for the raw intensities obtained from the iterative
nonlinear least-squares fitting algorithm (B). Distributions in (A) pass both the F test and the t test, while the distributions in (B) fail the F test.
These results are consistent with the orientation-corrected, per-crystal SHG intensities being the primary mechanism enabling discrimination of the
orthorhombic (blue) and monoclinic (red) crystal structures.
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calculated F value for the distributions shown in Figure 6b is
also included in Table 1. Both the local-frame tensor elements
and the intensity-corrected local-frame tensor elements fail the
F test, as summarized in Table 1.
Collectively, these tests yield information on the primary
mechanisms responsible for discrimination in NOSE micros-
copy measurements of crystal forms. The raw polynomial
coefficients, which contain both intensity and polarization
information, pass the F test but fail the t test following LDA.
However, these data pass both the F and the t tests and are
statistically indistinguishable after removing the intensity
information from each set of polynomial coefficients on a
per-crystal basis. When considering only orientation-corrected,
per-crystal SHG intensities and no polarization-dependent
information, the results from the two crystal forms fail the F
test, indicating statistically significant discrimination. These
combined results are consistent with the disparity in
orientation-corrected, per-crystal SHG intensities between the
two samples serving as the primary discriminatory property
when laboratory-frame polynomial coefficients are used for the
discrimination.
These results are also consistent with diverse crystal
orientations being the next most dominant mechanism
dictating the value of the polynomial coefficients, suggesting
the potential for improved discrimination when using
orientation-corrected local-frame tensor elements instead of
Figure 5. Histograms of the raw local-frame tensor elements following LDA for orthorhombic (blue) and monoclinic (red) forms of D-mannitol. The
recovered distributions fail the F test with >99.99% confidence.
Figure 6. Scatter plot (A) and histograms following LDA (B) of the intensity-corrected local frame tensor elements for orthorhombic (blue) and
monoclinic (red) forms of D-mannitol. The scatter plot in (A) allows direct visualization of the increased variance in the intensity-corrected local-
frame tenor elements observed for the monoclinic structures relative to orthorhombic structures. The distributions shown in (B) fail the F test.
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laboratory-frame polynomial coefficients. Consistent with this
expectation, the calculated F values following LDA of the
derived local-frame tensor elements are significantly higher
(effectively infinite discrimination) than those found following
LDA of the laboratory-frame polynomial coefficients. These
results are consistent with increased separation observed
between the two structures once the orientation-dependence
of the nonlinear optical crystal response is removed. Fcalc for the
intensity-corrected local-frame tensor elements is greater than
Fcalc for the raw local-frame tensor elements. This increase
indicates that the discriminatory capability is further improved
when combining both the orientation-corrected per-crystal
SHG intensities and the local-frame polarization-dependence.
While orientation-corrected per-crystal SHG intensity
information alone may enable structure discrimination under
the experimental conditions in the present work, the confidence
in that discrimination further improves when also considering
polarization-dependent effects. Considering hypothetical NOSE
measurements with lower SNR than in the present study, it is
possible that discrimination could be enabled when considering
these combined observables, but not feasible when considering
only the orientation-corrected per-crystal SHG activities. It is
also worth noting that the scalar intensities found via the
nonlinear fitting algorithm in the present study differ from the
scalar intensity quantities in previous works. Scalar intensities
found through single-point measurements on bulk powdered
samples26−28 are sensitive not only to crystal polymorphic
form, but also to the presence or absence of phase matching,
the packing density, orientation distribution, and particle size
distribution of the sample. Several of these sources of ambiguity
have been addressed in more recent studies based on SHG
microscopy of powders.42 In contrast, the single-crystal,
orientation-corrected intensities presented here-in have largely
removed the dependence on packing density, orientation, and
phase-matching, further isolating the effects from polymor-
phism on the overall SHG intensity.
While the recovery of local-frame tensor elements was
demonstrated for the P212121 and P21 crystal classes in this
work, this strategy can be generalized to other crystal classes.
With the exception of rare octahedral chiral symmetries, SHG is
bulk allowed in all chiral crystal structures. Discrimination of
crystals structures by NOSE should in theory be possible under
these same constraints. The general ability of NOSE for
discriminating specific crystal classes is highly dependent on the
differences in molecular packing and orientation relative to the
crystallographic coordinates, such that general conclusions
should be made cautiously. Fortunately, relatively simple
molecular-level calculations can provide reasonable estimates
regarding the discriminatory capability of NOSE. Previous work
has demonstrated good correspondence between ab initio
predictions and experimental orientationally averaged SHG
activities.43 It is reasonable to expect similar reliability for
prediction of the polarization-dependent differences between
unique crystal forms. The current experimental architecture
yields limits on the number of local-frame tensor elements
recoverable via the iterative nonlinear least-squares analysis.
However, the addition of a quarter wave plate to the beam path
(presample) and repetition of the data acquisition at multiple
wave-plate rotations could provide additional independent
measurements and enable the recovery of a higher number of
local-frame tensor elements.
The use of NOSE for polymorph discrimination offers
several other advantages consistent with practical consider-
ations in performing HT crystallization studies for crystal form
discovery. While the polymorphs were synthesized at a relative
large (∼g) scale for ease of preparation, the actual micro-
crystalline mass used for discrimination is estimated to be
approximately 1 μg. This mass is consistent with per-well mass
values typically encountered in small-volume HT crystallization
studies. Additionally, NOSE imaging can be performed rapidly.
Each FOV in the present study took approximately 7 s to
acquire, although the observed SNR in the SHG images
(∼300) and high confidence in the subsequent statistical tests
suggests this acquisition time could be significantly reduced. In
any measurement, the limits of quantitation are always greater
than the limits of detection, including the present case. One of
the key enabling advantages of the NOSE measurement
approach is dramatic reduction in the 1/f noise relative to
analogous wave plate-based measurements, such that signifi-
cantly greater confidence can be assigned with shorter
measurement times. NOSE imaging at video rates has been
demonstrated previously.31 Additionally, while the two
polymorphic forms were kept physically separated to ease
validation (e.g., PXRD) in this proof-of-concept study, the
analysis presented here (performed on a per-crystal basis) is
readily applicable to mixtures of polymorphic forms. Within the
assumption that the individual crystals within a multistructure
mixture could be prepared in a manner that minimizes physical
crystal overlap, the methodologies presented in this manuscript
should directly enable structure discrimination.
Finally, it is worth emphasizing that the discrimination
demonstrated in this study is based solely on the SHG
measurements alone. Additional considerations such as crystal
habit (e.g., needle, plate, etc.) could provide additional
complementary indicators for polymorphism discrimination
based on image analysis. Given that the SHG is expected to be
largely independent of crystal habit, the two methods should be
largely orthogonal. Although not the primary subject of the
present study, additional discrimination capabilities are possible
by combining the NOSE measurements with polarization-
dependent laser transmittance microscopy, which is performed
concurrently with NOSE imaging. Bright field imaging is
commonly used to identify crystal formation (hits) and crystal
structures/habits in HT studies; the laser transmittance images
obtained in NOSE retain this imaging modality. A sample laser
transmittance image for each crystal form is shown in the
Supporting Information (Figure SI-3). Furthermore, the
polarized detection present on this channel allows recovery of
observables describing sample birefringence, another modality
commonly used in the assessment of crystal forms in HT
studies. However, the polarization-dependent changes arising
from birefringence were generally relatively subtle compared to
analysis by NOSE and highly dependent on the thickness of the
crystals.
These collective results suggest the viability of NOSE for
rapid polymorph discrimination for fast prescreening. This first
study was limited to the discrimination of two polymorphic
forms. In principle, extension to systems exhibiting many
accessible polymorphic forms simply represents expansion to n-
class LDA. In practice, the high degree of discrimination
achieved from recovery of the local-frame tensor elements and
intensities suggests optimism in generalization of this approach
to higher numbers of crystal forms.
The recovery of crystal orientation angles also has the
potential to benefit analysis of HT crystallizations by PXRD
and Raman. In the event that an outlier is detected based on
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NOSE microscopy as demonstrated herein, a natural next step
would be to confirm or refute by an orthogonal method such as
PXRD or Raman. The limited number of crystals typically
found in modern solid form screens can complicate analysis by
both methods due to significant preferred orientation effects in
the observed scattering patterns.24,25 Accounting for these
effects through increased data acquisition (e.g., repeating the
measurement at a variety of sample orientations) requires
significant additional analysis times. The crystal orientation
information recovered through NOSE could potentially be fed
into these pipelines and used to correct for preferred
orientation effects, helping to alleviate these additional
bottlenecks in crystal characterization. In this manner, NOSE
measurements may serve double-duty, first for identification of
outliers and next to aid in subsequent orthogonal analyses.
■ CONCLUSION
NOSE microscopy has been shown to allow highly confident
(>99.99%) discrimination of orthorhombic and monoclinic
crystal forms of D-mannitol in a few seconds of total
measurement time. Rapid (8 MHz) polarization modulation
allows the recovery of a set of polynomial coefficients for each
sample at <7 s per FOV with a SNR of ∼300. These coefficients
enabled discrimination directly, following two-class LDA for
dimension reduction. However, substantial improvements in
discrimination were achieved by correcting the polarization-
dependent measurements for local crystal orientation. Trans-
formation of the polarization-dependent response to the local-
frame allowed direct recovery of the tensor elements for the
P212121 crystal form and confident detection of the P21 crystals
that were not well described by those recovered local-frame
tensor elements. Furthermore, the complete analysis was
performed using only ∼1 μg of crystalline material. These
collective results have the potential to help address bottlenecks




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.anal-
chem.6b00057.
Example single color Fourier coefficient images, images
of in-plane crystal orientation from the OrientationJ
plug-in (NIH ImageJ), polarized laser transmittance
images, and an analytical/graphical explanation of the
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